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ABSTRACT 
Proteins bind to DNA to form switches and circuits that control the flow of genetic 
information from DNA sequence to the physical components of cells and organisms. The 
dynamic performance of genetic switches depends on the coupling of the common processes of 
transcription and translation to protein-specific folding, assembly and binding reactions. For 
many model circuits protein dimerization and DNA binding are fast relative to the time scale of 
transcription and translation and thus amenable to modeling by statistical thermodynamics.  In 
these cases, the distribution of proteins between monomers and dimers and between nonspecific 
and specific DNA complexes can be simply predicted from the measured free energy of each of 
the states.  
Lambda Cro is unusual. Dimers of Cro are required to recognize operator DNA and 
repress transcription, but dimerization is weak compared to DNA binding and slow relative to 
other processes required for its production and function. Dimerization limits both the equilibrium 
extent and the kinetic rate of operator binding in vitro. To test the hypothesis that these unusual 
dimerization characteristics are critical to Cro‟s regulatory function in living cells, “single-chain 
dimer” variants of Cro (scCro) that eliminate the slow dimerization step have been characterized. 
Fluorophore-conjugated, single-cysteine Cro variants have been used to facilitate the 
investigations of the equilibria and kinetics of DNA binding by fluorescence resonance energy 
transfer (FRET). Single-chain Cro dimer binds to operator DNA more than 100-fold faster and 
tighter than wild type Cro. A secondary mutation (scCro(PFPS-AWSG)) that replaces two proline 
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residues in the context of scCro reduces its equilibrium affinity for operator DNA to a level 
similar to wild type Cro but binds at a similar rate to scCro 
Extrapolation from test-tube to cellular conditions is complicated both by differences in 
solution conditions and by additional complexity of the intracellular environment.  The factor 
most likely to affect DNA binding in each case is the cellular ionic environment and the presence 
of a million-fold excess of non-specific DNA binding sites that cumulatively compete with the 
operator site for Cro binding. To address these differences DNA binding studies as a function of 
salt and added nonspecific DNA have been undertaken. Kinetic and equilibrium studies of 
complex formation have been completed by direct FRET measurements and by competition 
studies with unlabeled proteins and DNA. Specificity ratios obtained for lambda OR3 versus non-
specific DNA range from 10
3
 to 10
6
, depending on the Cro variants and the salt concentration. 
Although the scCro and scCroPFPS-AWSG have similar salt dependences for operator binding, 
scCroPFPS-AWSG has a significantly higher salt dependence for nonspecific binding. These results 
will provide inputs for mathematical models of the dynamics and equilibrium extent of 
repression by Cro variants in living cells. 
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INTRODUCTION 
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1.1 INTRODUCTION 
The regulation of gene expression relies on multiple processes, like protein assembly, 
protein-DNA binding and cooperativity. Measurement of the physical chemical properties of 
these regulatory events provides the necessary information from which conceptual, predictive 
models can be developed to translate the molecular interaction properties into the “whole 
system” physiology (Ackers et al., 1982; Alberts, 1998). The lambda genetic switch has been 
an important paradigm for the modeling of genetic regulatory networks. Cro is one of the two 
primary regulators along with lambda repressor (CI) of the lambda switch. The Cro 
polypeptide contains 66 amino acids. Cro has been studied genetically, biochemically and 
structurally. The mechanism of Cro repression is fundamental to understanding gene 
regulation in bacteriophage lambda.   
The decision whether to replicate and finally lyse its bacterial host cell or repress viral 
gene expression and integrate into the host chromosome to form a lysogen is due to the 
competition between Cro and CI. Like many bacterial repressors Cro binds to DNA as a dimer 
(Brennan et al.,1986; Jana et al., 1997).The assembly of Cro dimers is relatively slow and 
weak (Satumba and Mossing 2002). The lysogenic state is stable unless it is perturbed by the 
DNA-damage response of the host when degradation of CI leads to switching to the lytic state. 
In absence of the DNA-damage response, escape from lysogeny is less than 10
-8
 /cell 
generation (Little & Michalowski, 2010). The ultimate stability of the lysogenic state may 
depend critically on the slow assembly of Cro monomers to yield active Cro dimer. A 
significant delay between the production of Cro monomers and the assembly of active Cro 
dimers will lower the probability for escape from the lysogenic state. 
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In many models of transcriptional regulation both the protein-DNA binding reactions 
and the protein dimerization reactions are rapid on the time scale of RNA transcription and 
protein translation and thus simply modeled as equilibrium processes. The assembly of Cro 
dimers is however very slow (Satumba and Mossing 2002) which is unusual for site-specific 
DNA binding proteins. The slow Cro dimerization is important for the detailed gene 
expression response curves, and especially for the rare switching events that determine 
lysogen stabilities. Previous studies have shown that folding and assembly of the lambda Cro 
repressor from the denatured states were limited by proline isomerization. Limitation to DNA 
binding due to slow dimerization can be overcome in single-chain Cro (scCro) which no 
longer need to dimerize. We have built scCro variants that will allow us to separate kinetic 
from thermodynamic effects.  
Extrapolation from „in vitro‟ to „in vivo‟ (test tube to cellular) conditions is complicated 
both by differences in solution conditions and by additional complexity of the intracellular 
environment. The factor most likely to affect DNA binding in each case is the cellular ionic 
environment and the presence of a million-fold excess of non-specific DNA binding sites that 
cumulatively compete with the operator site for Cro binding.  
Most protein-DNA interactions exhibit substantial polyelectrolyte effects (Record 
1998). Depending on the distribution of charges on the protein and the coupled assembly 
reactions, net cations release from the DNA can be partially compensated by net anions 
release from the protein. The thermodynamic driving force associated with ion release 
depends on the bulk ion concentration. The net number of ions released can be estimated from 
the log / log slope of Kd vs [K
+
]. 
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Both specific and non-specific protein DNA interactions are salt dependent.  So in order 
to make a reasonable extrapolation from in vitro conditions to in vivo, one needs estimates not 
just for the relative binding affinity and the number of non-specific sites.  One also needs to 
know the relative salt dependence.  
This dissertation will characterize the biophysical properties of these scCro variants in 
anticipation of their incorporations into model control circuits.  
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1.2 DISSERTATION OUTLINE 
Chapter 1 introduces the background that forms the basis for our studies. The lambda 
genetics is used as a prototypic example of transcriptional regulation conferred by linked 
protein–protein and protein–DNA interactions. Cro, one of the two primary regulators of the 
lambda switch, competes with CI to determine the fate of a host cell by interaction with operator 
sites. The structures of Cro and some Cro variants are described. Cro repressor-DNA interactions 
were expressed by thermodynamic models. 
Chapter 2 describes the constructions of scCro variants. Several scCro variants were 
constructed and purified. The mutations were confirmed by DNA sequencing and protein 
expression. These scCro variants were then labeled with 5-iodoacetamidofluorescein (5-IAF) at 
the single cysteine residue to facilitate the investigations of the equilibria and kinetics of DNA 
binding by fluorescence resonance energy transfer (FRET). 
Chapter 3 describes FRET studies of operator DNA binding by scCro variants. Kinetic 
and equilibrium studies have been completed by direct FRET measurements and by competition 
studies. scCro variant (scCroPFPS-AWSG) has near wild type Cro binding affinity but associates and 
dissociates hundreds of times faster.  
Chapter 4 describes DNA binding studies of scCro variants-nonspecific DNA (nsDNA) 
interactions and salt effects on scCro variants-specific DNA interactions. Competition 
experiments were performed by addition excess of the unlabeled nsDNA to protein-DNA 
complex. The binding affinity of specific interaction is 100-fold over nsDNA interaction for wild 
type Cro but 10000-fold for scCro variants. Dependences of association rate constants, 
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dissociation rate constants and equilibrium constants on [K
+
] were investigated. From the plots 
of the logarithm of Kd   as a function of the logarithm of [K
+
] we can conclude that scCro 
variants-specific DNA interactions, as well as wild type Cro, have shown moderate dependences 
on salt concentration. 
Salt effects on nonspecific interactions were also investigated. Compared to the effect of 
salt on specific binding, nonspecific DNA interactions show drastically different salt sensitivity.  
 
1.3 PROTEINS AND GENE EXPRESSION 
Proteins are the principle actors in living organisms. They are products of the expression 
of genes encoding the genetic information in the organism's genetic material (DNA or RNA). 
Genes are sequences of DNA that encode RNAs and determine the structure of macro-molecules 
that constitute the machinery of living cells. At any given time, each cell transcribes only a 
subset of its genes into RNA to direct production of other molecules. Transcription is the first 
step leading to gene expression. During transcription an enzyme known as RNA polymerase use 
the sequence along one of double stranded DNA as a template to synthesize a linear molecule 
called messenger RNAs (mRNAs). Messenger RNAs are decoded by the ribosome to construct a 
specific amino acid chain, or polypeptide, the primary structure of proteins. The linear 
polypeptide chains will later fold into an active protein. In bacteria, as the 5‟ end of the mRNA is 
accessible the process of translation begins even though the transcription is not completed yet.  
Proteins are well known as enzymes. Almost all the biochemical reactions in the cell are 
catalyzed by one or more enzymes. The chief characteristic of proteins is their ability to bind 
  
7 
 
other molecules specifically and tightly. The cells are able to reproduce, to sense, and to respond 
to the environment due to a complex network of interactions between protein and other 
molecules. However, Proteins are produced in the different quantity at different time. The 
expression of proteins is regulated and stimulated by internal and environmental factors and 
finally is tuned up or down in response to metabolic demands. It is very important to understand 
the mechanisms responsible for the control of genes and the circuits created by many linked 
genes. Regulatory networks were first studied in bacteria and bacterial viruses. One of the most 
simple and wildly studied regulatory systems is lambda genetic switch which allow researchers 
to derive the basic mechanism of gene expression and provided a paradigm for the understanding 
of gene expression in higher organisms. 
 
1.4 BACTERIOPHAGE LAMBDA GENETIC SWITCH 
Genes are sequences of DNA that encode RNAs and determine the structure of macro-
molecules that constitute the machinery of living cells. At any given time, each cell transcribes 
only a subset of its genes into RNA to direct production of other molecules. Genes that are 
actually being transcribed into RNA are “on” and those not expressed are “off”.  
Transcription initiation is highly regulated by the binding of special proteins to specific 
sites on the DNA. A negative regulator prevents transcription, and a positive regulator stimulates 
transcription of a gene. It is very important to understand the mechanisms responsible for the 
control of genes and the circuits created by many linked genes. The lambda genetic switch is one 
of the simplest and most widely studied systems. Substantial genetic and structural information is 
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available. The lambda switch has been used for years to derive the basic mechanisms of gene 
expression at increasing levels of sophistication and provides a paradigm for the understanding 
of gene expression in higher organisms (Ptashne and Gann 2002; Ptashne 2004).  
The Lambda virion is a particle consisting of a head, containing double-stranded linear 
DNA molecule in an icosahedral protein coat and a tail with fibers. The phage particle is 
infectious: it recognizes and binds to its host, E. coli, causing DNA in the head of the phage to be 
ejected through the tail fibers into the cytoplasm of the bacterial cell, while leaving its coat 
behind.  
There are two fates awaiting λ-infected bacterium. Usually, a “lytic cycle” ensues, where 
the lambda DNA is extensively replicated and the genes for head, tail and lysis proteins are 
expressed. New phage particles are formed within the bacterium, and some 45 minutes following 
infection the bacterium lyses and releases about 100 progeny phage. However, in some cells the 
phage DNA may integrate itself into the host cell chromosome. In this lysogenic state, the λ 
DNA is called a prophage and remains dormant at a specific site within the host‟s genome 
without apparent harm to the host. As the bacterium grows and divides, the prophage is passively 
replicated and confers immunity to the cell against infection by another lambda phage. Once 
established, the lysogenic state is extremely stable. However, this state can switch to the lytic 
state by a pathway called prophage induction (right streamlined diagram in Figure 1.1), which 
operates through the host SOS response (Little and Mount 1982; Ptashne 2004). DNA damage 
prompts RecA, a protein ordinarily involved in facilitating recombination between DNA 
molecules, to become a special kind of protease, which facilitates self-cleavage by  repressor, 
thereby triggering expression of lytic genes and induction (Little 1984) 
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Figure 1.1: Alternative life cycles of bacteriophage lambda 
As an obligate parasite, bacteriophage  must inject its DNA into the bacterium to 
multiply. Upon infection, the phage has two mechanisms of action: In the lytic pathway (left 
streamlined diagram in Figure 1.1), the cell executes a pattern of viral gene expression, 
replicates the viral DNA, makes around 100 new virions in about 45 minutes, and finally lyses. 
In the lysogenic pathway (right streamlined diagram in Figure 1.1), the viral DNA is physically 
integrated into the host genome where it is replicated when the host divides. Once established, 
the lysogenic state is extremely stable. However, this state can switch to the lytic state by a 
pathway called prophage induction (red arrows) by host SOS response. DNA damage results in 
activation of the host RecA protein which will stimulate the self-cleavage of CI, leading to its 
inactivation. The phage chromosome abandons its previously useful scheme of passive 
replication and enters the lytic pathway. 
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1.4.1 Phage lambda lysis–lysogeny decision circuit 
The lambda genetic switch that determines whether a phage reproduces and lyses the cell 
or whether it integrates into its host genome to become a prophage was among the first genetic 
switch to be studied and the system has contributed immensely to our present understanding of 
developmental pathways (Ptashne, Jeffrey et al., 1980). This well understood circuitry involves 
several interesting regulatory behaviors. 
The patterns of gene expression during lambda growth are summarized in Figure 1.2. 
There are three primary phases in the life cycle of phage λ (Ptashne 2004), very early, early, 
and late. The first two transcriptional patterns set the stages for the decision to lyse or lysogenize. 
In the very early stage, phage lambda has only three moderate or strong promoters, PL, PR and 
PR’, that are recognized by the host RNA polymerase. Transcription from PL causes expression of 
the anti-terminator protein, N. Transcription from PR causes expression of the anti-repressor 
protein, Cro. These transcribing RNA polymerase molecules stop just at the end of N and cro 
genes, respectively. Transcription from PR′ pauses after a short distance and no protein is 
expressed. In the early stage, N, works as a positive regulator (anti-terminator), turning on genes 
to the left of N including cIII and the recombination genes and genes to the right of Cro 
including cII, and the DNA replication genes – O and P, and Q.  At this point the pathway 
bifurcates, CII and CIII favor lysogenic growth; O and P are required for phage replication; and, 
Q, another anti-terminator protein like N, favors lytic growth by helping late lytic gene 
expression. 
The lysis-lysogeny decision is made in the late stage based on the relative activities of 
two competing regulatory proteins, CI ( repressor) and Cro (Johnson, Poteete et al., 1981). If CI 
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dominates, then lambda will go lysogenic; however if Cro dominates, then lambda will go lytic. 
In the lytic growth pathway, the genes for lysis and for production of heads and tails are 
expressed. The anti-terminator protein, Q, is required for expression of these genes. At the same 
time, Cro first binds OR3 to prevent further synthesis of repressor from PRM and then binds to OL 
to turn off the transcription initiated by PL. After sufficient Q has accumulated to activate 
production of protein coats that wrap up the newly synthesized DNA molecules, the cell is lysed. 
If the phage follows the lysogenic growth pathway, CII product will turn on cI and int. Int is a 
site specific recombinase that integrates the phage chromosome into the host chromosome. cI 
binds to OL and OR to turn on the transcription of its own gene as it turn off all the other phage 
genes. In summary, Cro is one of the first protein transcripts of λ DNA within ~ 5 seconds, while 
lambda repressor requires three sequential cycles of transcription and a minimum of 12 + 50 + 
14 seconds for the sequential production of N, cIII and cI.  
The decision between lysis and lysogeny comes down to the winner of the competition 
between Cro and CI for binding to the operators OL and OR (Figure 1.3) (Herskowitz and 
Hagen 1980). Both CI and Cro specifically bind the left and right operators (OL) and (OR). The 
key to the battle between Cro and CI is CII. If CII activity is high, then CI will be synthesized at 
high levels, binding of CI to the right operator (OR) will dominate over Cro, and lambda will go 
lysogenic (Kobiler, Rokney et al., 2005). The activity of CII depends on environmental 
conditions, the nutritional state of the host cell and multiplicity of infection. If the bacterial host 
is growing under rich conditions (plenty of nutrients), then  is more likely to go lytic (Kihara et 
al., 1997). Under poorer growth conditions or the multiplicity of infection (ratio of phage to host 
cells) is high (5 – 10 phages per infected cell), cII builds up to higher levels and stimulates the 
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production of cI and the establishment of lysogeny (Kourilsky and Knapp 1974; Herkowitz and 
Hagen 1980). In order to regulate the lysis-lysogeny decision as described above, it is critical 
that Cro does not dominate the regulation of OR before the cascade of events leading to cI 
production. The activity of the Cro repressor relative to cI must be delayed. 
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Figure 1.2 Patterns of lambda gene expression 
The genes shown in colors are on at each of the indicated stages of growth. The products 
of gene expression in each stage, according to the functions of the proteins they encode, are 
shown in different colors. Genes of related function are turned on and off together. These 
coordinately regulated genes lie in contiguous blocks except at the late lysogenic expression 
where only two genes, cI and int, are active. 
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Figure 1.3: Phage lambda lysis-lysogeny decision circuit 
Genes of the phage λ genome are shown in the colored boxes. Promoters are showed as 
arrowheads, transcripts as colored lines above or below the genes. Arrows in genes indicate the 
direction of transcription. 
The early transcripts for pL and pR promoters are shown as red arrows. The late 
transcript from pR‟ is indicated with black arrows. The CII-activated pI, pRE, and pAQ 
transcripts are indicated with purple arrows. The pRM transcript activated by CI is a green arrow. 
The operators OL and OR where CI and Cro bind are shown next to the pL and pR promoters.  
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1.5 CRO REPRESSOR  
            Cro, a regulatory protein of the lambdoid family of bacteriophages (Campbell 1994; Hall 
et al., 2011), works in opposition to the phage's repressor to control the genetic switch that 
determines whether lytic or lysogenic cycle will follow infection. Lambda Cro is relatively 
small, only 66 amino acids folded into three α-helical regions and three β-strands. Cro functions 
as a homodimer by binding to the two operator half sites (Hsiang, Cole et al., 1977; Roberts, 
Shimatake et al., 1977).  
 
1.5.1 Wild type Cro 
The three dimensional structure of wild type Cro has been determined by X-Ray 
crystallography and Nuclear Magnetic Resonance (NMR) (Anderson, Ohlendorf et al., 1981; 
Matsuo, Shirakawa et al., 1995; Albright, Mossing et al., 1996; Albright, Mossing et al., 1998). 
Wild type Cro forms a stable homodimer of 66-residue subunits. Each subunit contains three α -
helixes and three β sheets: β1(residues 3-6), α1(residues 7-14), α2 (residues 16-23), α3 (residues 
27-35), β2(residues 40-45), β3(residues 49-56) (Anderson  et  al.,  1981) (Figure 1.4). Gly15 
connects directly from helix α1 to helix α2 (Douglas H. Ohlendorf et al., 1981). Two of these α –
helixes (α2 and α3) are separated by a short turn and are held at 550 with respect to one 
another.  α3, the recognition helix, fits into the major groove of the operator DNA. The β3 β3‟  
antiparallel  β-strands (residues  54-56  and  54„- 56„)  forms  the most part  of  the  dimer  
interface. The primary interface between monomers is a series of hydrogen bonds between 
residues A52, E54, K56, and F58 of each monomer. Main-chain hydrogen bonds occur between 
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N54 and O56, O54 and N56, N56 and O56, and O56 and N56 respectively. The surface areaof 
the interface is 1280 Å2, or 640 Å2 per half-dimer (Albright et al., 1996). Phe-58 from one 
monomer inserts into a hydrophobic pocket in the other monomer, forming a “ball-and-socket” 
interaction and is responsible for 180Å2 of a total of 640 Å2 of accessible surface buried in the 
dimer interface (Albright, Mossing et al., 1996). Phe 58 is at the apex of a sharp bend from 
which it extends into the hydrophobic core (Albright, Mossing et al., 1996) which is enclosed by 
Leu 7, Leu 23, Val 25, Ala 29, Ile 30, Ala 33, Ile 40, Leu 42, Ala 52, and Pro 59 and is covered 
by Arg 38 and Glu 54, which form a salt bridge. The tip of the aromatic ring points toward the 
center of the recognition helix (R3) near the main chain between Ala 29 and Ile 30. 
              Peptide bonds in proteins in the majority of cases exist in the trans configuration 
(Ramachandran and Sasisekharan, 1968). In the native Cro dimer, the K56 – P57 peptide bond is 
in the trans configuration while the F58 – P59 is cis. The K56-K57 peptide bond is expected to 
remain predominantly in the native trans configuration and 77% of the F58-P59 peptide is 
expected to convert from cis to trans. Interconversion of the cis and trans configurations of the 
peptide bonds that precede proline residues is a slow process (Fischer et al., 1984). Slow phases 
in protein folding have been attributed to proline isomerization (Schmid 1982; Schreiber and 
Fersht 1993; Aronsson et al., 1997; Kamen and Woody, 2002; Wedemeyer et al., 2002). 
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Figure 1.4 Structure of lambda Cro repressor 
Ribbon diagram shows the wild-type (wt) Cro dimer structure (Ohlendorf, Tronrud et al., 
1998) (5cro.pdb). Only the first 61 residues are visible in the crystal structure. Some residues 
side chains in one subunit and residue 58 are shown as ball-and-stick model. There are three α–
helices and three β–sheets in each subunit of Cro, which are shown in different colors. The 
primary and secondary structures of Cro are also illustrated. The shading of the bars below the 
sequence represents the solvent accessible surface area for each residue. The figure was drawn 
with the program Molscript (Kraulis 1991). 
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1.5.2 Cro variants 
            For many model circuits, protein dimerization and DNA binding are fast relative to the 
time scale of transcription and translation and thus amenable to modeling by statistical 
thermodynamics (Gray Ackers, Madeline Shea, 1981).  Lambda Cro is unusual. Cro dimerization 
is weak compared to DNA binding and slow relative to other processes required for its 
production and function. Weak dimerization limits both the equilibrium extent and the kinetic 
rate of operator binding. Previous studies showed that the slow dimer assembly from the 
unfolded state is complicated because of the competing monomeric forms and proline 
isomerization (Satumba, W. J. & Mossing, M. C. (2002).). 
           scCro dimers were constructed by connecting the N-terminus of one subunit with the C-
terminus of next by a polypeptide linker (AGTGGSGG) (Jana, R; 1998). scCro eliminates the 
slow dimerization step and binds to DNA hundreds of times faster and more strongly than wtCro. 
Refolding of scCro however is slow. Rates are similar to the proline isomerization limited rates 
observed in the dimer and engineered monomer. In the native dimer, two prolines (57 and 59) 
locate at F58‟s flanks. The K56-P57 peptide bond is in the trans configuration while the F58-P59 
bond is cis.  The interconversion of the cis and trans configuration of the peptide bonds upon 
dimerization is a slow process (Fischer et al., 1984). From previous work we know P57 and F58 
have been successfully replaced in the dimer context (Pakula et al., 1986; Mossing and Sauer 
1990). Subsequent studies showed that residue 58 could also be replaced by the third aromatic 
residue, tryptophan. The substitutions of P59 that will enable protein to still fold, dimerize and 
ultimately bind to DNA is a big challenge. As the simplest of the naturally occurring 20 amino 
acids, with a single hydrogen atom in its side chain glycine is a good candidate amino acid the 
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most flexibility to replace this proline. Any perturbation of the amino acid sequence of a protein 
can affect that protein„s stability and interaction with DNA. Proline replacement was designed to 
trade off some DNA binding affinity for a faster rate in single chain proteins to create a protein 
that both assembles rapidly and binds tightly.  
 This design may also enable us to isolate kinetic from equilibrium effects. Our studies 
showed that scCro without one set of prolines (scCro(PFPS-AWSG)) binds operator DNA hundreds 
times faster than wild type Cro but with a close binding affinity to wild type Cro. scCro(PFPS-AWSG)) 
allows us to isolate the effects of kinetics and assess whether thermodynamic models are 
sufficient to describe simple Cro regulatory circuits. 
 
1.5.3 Cro-DNA interactions 
            Protein-DNA interactions play a key role in vital processes such as gene regulation. The 
developmental decision for phage  either to lysogenize or to lyse its host cell has been 
classically described as a competition between Cro and the lambda repressor cI (Johnson, Poteete 
et al., 1981). Anderson et al., 1981 reported that Cro uses a helix-turn-helix motif in binding 
DNA and since then this motif has been found to play a similar role in other DNA binding 
proteins (Kolkhof et al., 1992; Roy et al., 2002; Shearwin et al., 2002). Cro dimer binds the two 
operator half sites, with the recognition helix of each monomer (α3) inserted into the DNA's 
major groove. The α3 recognition helices are oriented with their axes parallel to the major 
groove. The side chains of each helix are thus positioned to interact with the edges of base pairs 
on the floor of the groove. Cro can bind to six sequence-specific sites, each of which is a slightly 
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different 17-bp DNA segment with approximate twofold sequence symmetry (Maniatis et al., 
1975). Cro binds to the three sites in OR with binding affinity order of OR3>OR2=OR1 and to the 
three sites in OL with binding affinity order of OL1>OL2=OL3. Previous studies showed that Cro 
binding to OR3 plays a critical role in blocking the transcription of PR. Cro functions as a 
homodimer. Cro must fold, dimerize quickly enough and then bind operator sites to repress the 
transcription of cI genes and win the competition. ScCro constructed by connecting the c-
terminal of one subunit and N-terminal of the next one showed hundreds times faster operator 
DNA binding rate and affinity (Jana and Mossing, 1998). This is further evidence that 
dimerization is weak and limits DNA binding of Cro. In the absence of DNA Cro has been 
shown to be mostly monomeric. Dissociation constants have been reported in the 10
-6
 M (Jana et 
al., 1997) and 10
-7
 M range (Darling et al., 2000). An important question that is addressed in this 
thesis is that slow assembly of Cro play an important role in regulation of the lambda switch. 
Protein and nucleic acid interact via complementarity of molecular surfaces. Although 
direct interactions between atoms in the respective macromolecular partners can be listed and 
analyzed, water and small-molecule co-solutes can often provide the bulk of the driving force for 
the interaction (Record, Zhang and Anderson 1998). The dominant non-covalent forces for 
macromolecular interaction are the hydrophobic effect and polyelectrolyte effect. DNA is a 
polyelectrolyte. The high charge density of phosphodiester backbone results in condensation of 
counterions to neutralize the bulk of the charge on the phosphates. In solution of monovalent 
salts at neutral pH DNA phosphates each entrap ~ 0.88 counterions in the local environment. In 
this sense DNA behaves like a nearly undissociated salt. The polyelectrolyte effect arises from 
tightly bound counter-ions that are displaced during the formation of macromoecular complex. 
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Fundamentally there is a parallelism between the hydrophobic effect and polyelectrolyte effect. 
Self-association of nonpolar groups releases water; binding of an oligocation to a polyelectrolyte 
release electrolyte ions. Consequently both of these processes are exchange reactions (Record et 
al., 1978). Because protein-DNA interactions are multiple equilibria involving many solution 
components, Kobs are critically dependent on the concentration of electrolyte and buffer ions 
present. In chapter IV the competition of Cro variants DNA interactions from small ions will be 
described. 
1.6 STATISTICAL THERMODYNAMIC MODELS TO DESCRIBE GENE CIRCUITS 
1.6.1 Thermodynamic model 
Genetic switches are composed of regulatory proteins and their cognate DNA binding 
sites. To understand the performance of a genetic switch, it is important to obtain detailed 
knowledge about the physical and chemical properties of the system (Alberts, 1998). For most 
proteins, the dimerization and DNA binding are fast relative to the time scale of transcription and 
translation and thus amenable to modeling by statistical thermodynamics. A model based on 
statistical thermodynamics is sufficient to account for some of the known physiological 
properties of the repressor-operator regulatory system (Ackers, 1982). In such models, the 
distribution of proteins between monomers and dimers and between nonspecific and specific 
DNA complexes can be simply predicted from the measured free energy of each of the states.  
Takeda et al., (1989) have reported the effects of systematic base substitutions upon the 
free energy of Cro-DNA associations. Based on the assumption that occupancy of operator sites 
by repressor dimers and the resulting effects on gene transcription are determined by equilibrium 
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statistical thermodynamic probabilities, each operator configuration can be ascribed an exact 
expression of its probability as a function of repressor concentration and free energy (related to 
binding affinity). Quantitative expressions that describe Cro dimer binding at individual operator 
sites are constructed by considering the relative probability, fs, of each operator configuration 
(Ackers et al., 1982) 
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Table 1-1: Microscopic configurations and free energies for the operator-Cro 
system OR 
 
 
 
 
 
 
 
 
 
 
 
 
The probability fs for binding the system in one state: 
    
   (      ⁄ ) [    ]
 
∑    (      ⁄ ) [    ]   
 
Where R is the gas constant, T is the absolute temperature. [cro2] is the concentration of unbound 
Cro repressor dimers, and j is the number of Cro repressor dimers bound to an operator in the s 
configuration (e.g. 0, 1, 2, or 3). The summation of s is taken from 0 through 8. The probability, 
fs, is the fractional contribution of the microstate free energies (△Gs) to that of the overall 
population (Ʃ△Gs) at a particular protein concentration. Occupancy of sites OR1 and OR2 by cro 
Species Configuration Free energy 
contributions 
Free 
energy(∆Gs),kcal 
S OR
3
 OR
2
 OR
1
 
1 0 0 0 Reference state 0 
2 0 0 C ΔG
1
 -10.8 
3 0 C 0 ΔG
2
 -10.8 
4 C 0 0 ΔG
3
 -12.1 
5 0 C C ΔG
1
+ΔG
2
+ΔG
12
 -21.6 
6 C 0 C ΔG
1
+ΔG
3
+ΔG
13
 -22.9 
7 C C 0 ΔG
2
+ΔG
3
+ΔG
23
 -22.9 
8 C C C ΔG
1
+ΔG
2
+ΔG
3
+ΔG1
23
 -33.7 
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contributes to PR repression, while occupancy of OR3 contributes to repression at PRM. Once the 
probabilities for each of the operator states are known, the binding of repressor to each operator 
site in the full cooperative system can be described. For example, the total occupancy of OR3 is 
given by: 
                       
The activities of the two OR-controlled promoters (PR and PRM) as a function of repressor 
concentration will be quantitatively predicted, and these predictions can then be compared with 
known physiological properties of the system. These parameters were then used to predict the in 
vivo behavior of the system.  
1.6.2 Predicted behavior of Cro and scCro bound to operator DNA 
Since Cro binds DNA as a dimer, but exists mostly as a monomer in solution, the overall 
reaction can be written as two coupled reactions: the first a dimerization reaction of identical Cro 
monomers and the second the dimer-DNA binding reaction. The two reactions written as 
dissociations are: 
   
   
⇔            
[ ][ ]
[  ]
                                                                                              (   ) 
   
   
⇔             
[  ][ ]
[   ]
                                                                                         (   ) 
C is the active monomeric form of Cro repressor 
C2 is the active dimeric form of Cro repressor.  
O is operator DNA.  
Kd1 is the equilibrium dimer dissociation constant. 
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Kd2 is the equilibrium DNA-complex dissociation constant. 
At equilibrium both reactions are governed by dissociation constants: Kd1 and Kd2. Kd1 
has been measured by a variety of methods (Jana 1997, Jia 2005) as has the composite.  
The fraction of the operator sites occupied by Cro dimer can be 
       Ө = C2 / (C2+Kd2)                                                                                 ( 1 – 3 )  
Substituting (C
2
/Kd1) for C2 in equation (3), we get 
                   Ө = C2 / (C2+ Kd1 Kd2)                                                                    ( 1 – 4 ) 
We can estimate Kd2-the dimer-DNA dissociation constant from Kd1 and the midpoint of 
the operator titration and we get Kd2=10
-12
M. 
Several scCro dimers have been constructed. In these proteins dimerization is no longer a 
required precursor to DNA binding. As observed operator binding affinity of scCro repressor is 
hundreds of times higher than wtCro. Although effectively decoupling dimerization and its slow 
kinetics from DNA binding, the very large increase affinity makes it hard to compare scCro to 
wtCro. In this work we examined the DNA binding characteristics of scCro variant which is 
expected to have a similar binding affinity and a similar saturation profile.  
Although the end products of Cro-DNA complex and scCro-DNA complex are similar, 
the composite binding reaction for wtCro is second order in Cro while the scCro reaction is first 
order in protein. 
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CHAPTER II 
CONSTRUCTIONS OF CRO VARIANTS 
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2.1 INTRODUCTION 
Cro dimers undergo dissociation into subunits at micromolar concentration range that are 
far in excess of those required for DNA binding (Jana, 1997). The observed dimer dissociation 
constant ((7 ±4) × 10
-6
 M) dictates that at a total Cro subunit concentration of 1× 10
-9
 M only two 
subunits in 7000 will form dimers at equilibrium. These rare dimers must therefore bind to DNA 
with very high affinity. The predicted large pool of free subunits and very limited population of 
free assembled dimers also suggests that dimer assembly might be a kinetically limiting process 
in Cro dimer-DNA association (Mossing, 1997). scCro plasmids were constructed by connecting 
the N-terminus of one subunit and C-terminus of the next one with a polypeptide (Jana et al., 
1997). Studies of equilibrium and kinetic DNA binding by scCro were completed by gel shift 
assay (Jana et al., 1997). The engineered Cro dimer shows dramatically higher binding affinity 
and faster kinetics without slow dimer assembly.  
Ideally we would like to construct a Cro dimer in which nothing was changed except the 
ability of its subunits to dissociate from each other. If dimer dissociation could be prevented, 
while leaving the structure and function of the protein unperturbed, the concentration of protein 
required for saturation of an operator site should reveal the intrinsic dimer affinity. Refolding of 
scCro dimers however is slow. Rates are similar to the proline isomerization limited rates 
observed in the dimer and engineered monomer. 
In the native dimer, two prolines (57 and 59) flank F58. The K56-P57 peptide bond is in 
the trans configuration while the F58-P59 bond is cis.  The interconversion of the cis and trans 
configuration of the peptide bonds upon dimerization is a slow process. Proline replacement was 
designed to trade off some DNA binding affinity for a faster rate in single chain proteins so that 
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we can create a protein with a close binding affinity and similar saturation profile to wtCro. 
Prolines 57 and 59 were replaced in combinatorial mutagenesis experiments by Satumba (2003 
dissertation).  Previous mutagenesis studies identified several functional replacements for 
residues 57 and 58 (Pakula et al., 1986; Mossing and Sauer 1990) but no functional replacement 
had been identified for Pro 59 and Ser 60 the residues involved in the only cis-peptide bond in 
the native Cro structure. To allow for additional flexibility in the polypeptide backbone in the 
region of the 58-59 peptide bonds a glycine was allowed as a substitute for serine 60. In one 
limited randomization scheme P57 and F58 were replaced Alanine and Tryptophan and P59, and 
S60 was replaced with Glycine or Serine (with equal probability).  The mutagenesis scheme can 
be denoted P57A F58W P59 (G/S) S60(G/S).  In a second experiment codons 57-60 were 
replaced combinatorial oligonucleotides designed to allow for a possible hydrophobic residue at 
position 59, P57A F58WP59(I/V/T/A/S/G) S60(G/S). Proline replacement variants were 
identified in the context both of the 66 residue wild-type polypeptide and 140 residue scCro8 
variant.            
Single cysteine variants of Cro were constructed by (Jia et al., 2005) to identify surface 
exposed positions in the protein where fluorophores could be conjugated with minimal effects on 
protein structure, stability dimer assembly or DNA binding. Among the cysteine variants that 
best met those criteria is N-terminally extended protein that adds a His-6 purification tag and a 
unique cysteine residue to the unstructured N-terminus of Cro. For this work we also chose the 
single cysteine in a Histidine Tag (N-C3-(H)6): MGCS(H)6SSGL) at the unstructured N terminus. 
Thus a fluorophore was labeled on this cysteine to investigate the characteristics of Cro variants-
DNA interactions by FRET. 
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2.2 MATERIALS AND METHODS 
2.2.1 Buffers and reagents 
            KP20 buffer contains 20 mM potassium phosphate, 1 mM EDTA, and 1.4 mM 2-
mercaptoethanol (βME), 100 μg/ml of bovine serum albumin (BSA, ordered from Sigma), 5% 
(v/v) glycerol for protein stability and fluorescence signal measurements at pH 7.0; KP200 buffer 
is KP20 plus 200 mM potassium chloride. All experiments were carried out in KP200 buffer 
unless otherwise indicated. Urea lysis buffer contains 50mM Tris.HCl, 100mM NaCl, 6M urea, 
10%sucrose and1.4mM βME. SDS loading buffer contains 2% SDS, 12% glycerol, 0.4 M tris 
base (pH 8.45), 0.00125% bromophenol blue, and 0.73 M βME. Restriction endonucleases (Ndel 
and Bgll) and DNA-modifying enzymes were obtained from New England Biolabs, Promega, 
Fisher, Stratagene, and Invitrogen. 5-iodoacetamidofluorescein (IAF) was purchased from 
Molecular Probes. Tetramethylrhodamine labeled OR3R and OR3F were purchased from IDT. 
B-PERTM Bacterial Protein Extraction Reagent was purchased from PIERCE. SP Sepharose
TM
 
Fast Flow resin was ordered from Amersham Biosciences. Restriction enzymes were obtained 
from NEB and Promega. The 46 bp hairpin oligonucleotide (OR3HP) with the sequence of OR3 
(5– TTTAT CCCTT GCGGT GATAA ATTTT TTTAT CACCG CAAGG GATAA A –3) was 
purchased from Trilink Biotech.  
JM109 (DE3) and BL21 (DE3) cells were obtained from laboratory stocks. The pET(-
)33b-N-His-C3Cro (Jia et al., 2005), pET(-)33b-N-His-smCro (Satumba‟s thesis, 2003).  
 
 
  
34 
 
2.3 CONSTRUCTION OF NHIS-C3-SINGLE-CHAIN CRO VARIANT 
2.3.1 Plasmids Purification, Digestion and Ligation 
           Single colonies of JM109 (DE3), bearing pET(-)33b plasmid, were obtained by streaking 
cells from glycerol freezer laboratory stocks on LB agar plates containing 50 μg/ml kanamycin 
(Kan) and grown overnight at 37 °C. 50 ml of culture medium (LB + 50 μg/ml Kan; LB/Kan) 
was inoculated with a single bacterial colony in 250 ml flask and grown overnight at 37 °C with 
vigorous shaking. The bacterial culture was pelleted by centrifugation. The StrataPrep® EF 
Plasmid Midiprep Kit (Stratagene) was used to purify the plasmid DNA. About 20 μg plasmid 
DNA was obtained from 50 ml of culture medium. The purified DNA was eluted with Tris⋅HCl 
buffer (10 Mm Tris base, adjust the Ph to 8.5 with HCl) and stored at 4 °C. 
A single-chain Cro variant that lacks one set of prolines at 57-59 (Nhis-C3-scCroPFPS-
AWSG) was constructed from Nhis-C3-scCro and N-His-scCroPFPS-AWSG. These genes were 
expressed from the plasmids consisting of PET(-)33b N-His-C3-Cro and PET(-)33b N-His-
scCroPFPS-AWSG vectors respectively in which the single-chain Cro genes were cloned between the 
NdeI and XhoI sites. Two restriction endonucleases, Ndel and Bgll, were used to cut the circular 
plasmids into two linear fragments. The digestion was carried out by incubating 1 units of 
enzyme per µg of DNA in Promega‟s buffer II at 370C for overnight. The reaction was then 
stopped by adding an excess amount of EDTA, which chelates the Mg++ required for enzymatic 
activity. DNA fragments from the reactions were separated on a 0.8% agarose gel, visualized by 
SYBR® Green staining and excised from gel. 
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DNA fragments were purified from agarose gel following the QIAEXII Agarose Gel 
extraction protocol. The purified DNA fragment Nhis-C3 was then annealed with scCroPFPS-AWSG 
fragment with T4 DNA ligase at 16
0
C overnight. The ligation results were checked by agarose 
gel.  
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Figure 2.1: pET(-)33b(+) H6-C3- scCroPFPS-AWSG plasmid and protein sequence  
  2.1a. The pET(-)33b H6-C3- scCroPFPS-AWSG plasmid has 5179 base pairs which was 
constructed by inserting the Ndel to Bgl1 fragment of pET(-)33b(+) H6-C3-Cro (including H6-
C3)  into the Ndel to Bgl1 fragment of pET(-)33b(+) H6-scCro(PFPS-AWSG) (including scCroPFPS-
AWSG.  H6-C3 is coded between Ncol and Ndel. scCroPFPS-AWSG is coded between Ndel and XhoI. 
Some special restriction sites around cro gene are also shown. The figure is drawn with the 
program PlasMapper Version 2.0 (http://wishart.biology.ualberta.ca/PlasMapper/). 
2.1b. indicates the sequences of H6-C3-scCroPFPS-AWSG gene, protein, and restriction sites 
on the fragment.  
b1 shows the sequence of the subunit of scCroPFPS-AWSG where the prolines were replaced. 
The black box shows the fragment including the residues of H6-C3 where the fluorophore was 
attached on the single cysteine (showed as a green star). The red box shows the proline 
replacement residues in one Cro subunit (upper are the residues of wtCro and lower are proline 
replacement residues). The blue box shows the polypeptides linker connecting two Cro subunits.  
b2 shows the sequence of the wild-type subunit of scCroPFPS-AWSG. The green box shows 
the proline residues.  
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  2.1a 
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2.1b NHis-C3-scCroPFP-AWG gene, protein sequence and restriction sites 
b1. Prolines replaced subunit of scCroPFPS-AWSG 
M      G      C*    S       H      H      H      H      H     H       S       S       G       L     H 
ATG GGC TGC AGC CAT CAT CAT CAT CAT CAC AGC AGC GGC CTG CAT 
NcoI                                          Fluorophore attachment and His Tag 
 
M1    E      Q       R       I       T      L       K      D      Y10  A      M      R       F      G     
ATG GAA CAA CGC ATA ACT TTA AAA GAT TAT GCA ATG CGC TTT GGC 
NdeI                                                DraI                                                                Bal I 
    Q       T       K      T     A20  K21     D      L     G       V      Y      Q      S       A     I30       
  CAA ACC AAG ACA GCT AAA GAT CTC GGC GTG TAT CAA AGC GCG ATC   
                                                            BglII 
  N       K      A       I       H       A     G       R      K     I40   F41    L      T      I       N        
AAC AAG GCC ATC CAT GCC GGC CGA AAA ATA TTT TTG ACT ATA AAC 
                                                                                                          P       F       P        S         
                                                                                                       CCC  TTC  CCG  AGT   
  A      D       G      S     V50    Y      A       E       E       V      K        A      W      S       G       
GCT GAT GGA TCC GTA TAC GCG GAA GAG GTA AAG   GCC TGG AGC GGC   
                                                                                                                scCroPFPS-AWSG   
 
   N      K       K      T       T     A66    A     G      T       G      G       S      G      G                                                                                  
AAC AAA AAA ACA ACA GCG GCC GGT ACC GGT GGC TCT GGC GGC                                      
                                                                             Peptide Linker 
 
    
b2. Wild type subunit of scCroPFP-AWG                                                                                  
 
  M       E       Q      R      I       T      L       K       D     Y      A      M      R      F     G           
ATG GAA CAA CGC ATA ACT TTA AAA GAT TAT GCA ATG CGC TTT GGC                
                                                                 DraI                                                    Bal I 
   Q      T       K      T       A      K     D       L      G      V      Y      Q       S      A       I      
CAA ACC AAG ACA GCT AAA GAT CTC GGC GTG TAT CAA AGC GCG ATC     
                                                    BglII                                                  
  N       K       A       I       H      A     G       R      K       I       F      L       T      I       N              
AAC AAG GCC ATC CAT GCC GGC CGA AAA ATA TTT TTG ACT ATA AAC     
 
   A      D       G       S      V      Y      A       E      E       V      K      P       F      P       S               
GCT GAT GGA TCC GTA TAC GCG GAA GAG GTA AAG CCC TTC CCG AGT     
   
   N      K       K      T       T      A 
AAC AAA AAA ACA ACA GCA 
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2.4 CONFIRMATION OF H6-C3 CYSTEINE 
2.4.1 Screen clones for expression. 
Sixteen single colonies were picked from the transformation plate of the constructed 
Nhis-C3-scCroPFP-AWG. The candidates were restreaked and inoculated into 1.5ml of liquid 
culture medium (LB/Kan). After overnight growth at 37 °C, 20 l of the culture was inoculated 
into fresh 3.8 ml of LB/Kan and grown in a rolling drum at 37 °C for 2 hours. Then 1ml was 
transferred to a new tube and the left 3mls was used to produce protein by addition of IPTG to a 
final concentration of 1mM. Cultures were incubated for another two hours. Bacterial cells were 
pelleted by centrifugation at 13,000 rpm for 100 seconds. The cells were lysed and crude protein 
mixtures were extracted with B-PER
TM
 Bacterial Protein Extraction Reagent. The lysate was 
mixed with 100 l resin pre-equilibrated with KP20 buffer and was spun at 5,000 rpm for 2 
minutes to pellet the protein-contained resin. The pellet was then washed twice with KP20 buffer. 
50 l KP20 with 1 M NaCl was used to elute the Cro proteins. To identify proteins containing 
cysteine residues, 20l of the eluted samples were labeled with 1mM 5-IAF (Jia 2005) and 
verified by running a 20% Tris-tricine gel (Schagger and Von Jagow 1987). The gel was soaked 
in water for 15 minutes to remove the excess dye and then photographed by UV 
transillumination. The gel was then stained for about 1 hour with Coomassie Brilliant Blue and 
destained overnight using a solution of methanol and acetic acid. If the Nhis-C3-mutation is 
successful, the bright band for the dye-labeled Cro when the picture was taken under UV and the 
blue band of Cro protein after the procedure of stain/destain can be seen. Six or more of the 
sixteen single colonies have passed the test for each of Nhis-C3- scCroPFPS-AWSG. 
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2.4.2 DNA Sequencing 
           The candidates that pass the protein assay then were subjected to DNA sequencing to 
confirm the mutations. The plasmids for all the candidates were purified with the StrataPrep® EF 
Plasmid Midiprep Kit. The purified DNA was eluted with TrisHCl buffer (pH 8.5, 10mM). 
DNA sequencing experiments were done by using a Beckman Coulter kit (CEQ™ DTCS Quick 
Start Kit, P/N 608120) and the CEQ
TM 
2000 Dye Terminator Cycle Sequencing protocol.  
Experiments were performed on a CEQTM 8000 Beckman Coulter instrument according to the 
manual. DNA sequencing results confirm the sequence of the constructs (sequence showed in 
Figure 2.1b).   
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2.4.3 Quantify expression level on SDS page gel 
Single colonies were inoculated into 1 ml of LB/Kan. After overnight growth at 37 °C, 10 
l of the culture was inoculated into fresh 2 ml of LB/ Kan and grown for three hours. Then 1 ml 
of culture was taken out (saved as IPTG-) and the rest was induced with 1mM IPTG (IPTG+) 
and grown for additional two hours. The cells induced and uninduced were both harvested by 
spinning at 13,000 rpm in a microcentrifuge for 40 seconds. The supernatant was removed and 
the pellet was suspended with 200 l SDS loading buffer. The SDS/cell pellet mixtures were 
heated at 95 °C for 5 minutes and then cooled and spun again to pellet nucleic acids and cell 
walls. 10 l of the supernatant was loaded onto a Tris-tricine gel. The gel was first run at 100 V 
for 10 minutes and then 200 V for 40 minutes, stained for about one hour with Coomassie 
Brilliant Blue and destained using a solution of methanol and acetic acid. All of the variants 
express the proteins at similar levels. Figure 2.2 shows that scCro(PFPS-AWSG) is expressed at a 
high level and therefore it is likely to be stably folded. 
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Figure 2.2 Expression levels and final purity of scCro variants 
The SDS-PAGE gel shows induced expression level of scCroPFPS-AWSG and scCro. Lanes1 
is pure wild type Cro as a marker. Lane 2-5 contain alternating uninduced and induced lysates of 
JM109(DE3) cells expressing scCroPFPS-AWSG and scCro as indicated. Lanes 6-7 contain purified 
scCro and scCroPFPS-AWSG as indicated. 
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                    scCro   scCroPFPS-AWSG  
wtCro       -        +         -         + 
1         2          3          4          5          6        7 
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2.4.4 Protein Expression, Purification and  Labeling 
Nhis-C3- scCroPFPS-AWSG was expressed in JM109 (DE3) cells under the control of T7 
promoter. For protein expression, cells were grown with aeration at 37 °C in LB broth plus 
kanamycin (30µg/mL) to an OD600 ≈1. IPTG was added to a final concentration of 1 mM. The 
cultures were allowed to grow for 3 h at 37
o
C after induction. The cells were chilled to 4°C and 
harvested by centrifugation at 3000g. 
For initial characterization, each of the single-chain dimers were purified from 20 mL 
cultures. Cells were resuspended in 1 mL of urea lysis buffer, lysed by sonication, and cleared by 
centrifugation. Supernatant containing unadsorbed scCro repressor was applied to a cation 
exchange chromatography on a 1 mL HiTrap SP FF column (Pharmacia) and eluted in a gradient 
of 0-1 M KCl. Peak fractions (>80% pure) were used directly for fluorescein labeling and FRET 
experiments. 
Cro mutants containing the cysteine mutation are labeled with fluorescent dyes in order 
to examine kinetics and equilibrium using fluorescence spectroscopy.  The unique cysteine 
residues were modified with fluorescent dyes. 50 M protein was mixed with 1 mM TCEP to 
reduce the cysteine side chain. This mixture was directly incubated with 1 mM 5-
iodoacetomidofluorescein (5-IAF) (stored in DMF from Molecular Probes) for two hours in the 
dark at room temperature. The reaction was halted by adding a ten-fold excess of dithiothreitol 
(DTT), and the bulk of the unreacted dye was removed by dialysis against 20 mM potassium 
phosphate buffer overnight. The labeled protein was purified away from the remaining unreacted 
dye by cation exchange chromatography on a Hitrap SP sepharose (Pharmacia). Labeling 
efficiency was evaluated by comparing the absorbance of the protein at 280 nm to the 
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absorbance of the 5- IAF at 490nm. These concentrations are confirmed by Bradford assay 
(Bradford 1976). Concentration of the dye in the purified protein fractions were calculated using 
490 of 61,000 M-1cm-1 (molar absorption coefficient, pH 7) for5-IAF.  The protein 
concentrations for purified labeled proteins were determined either from the residual absorbance 
at 280 nm after subtracting out the dye contribution or by a Bradford assay (Bradford 1976). All 
fluorescence measurements were made on a Spex Fluoromax 3 (JY Horiba) instrument, in 
photon counting mode with an internal reference and a thermostatted sample holder. 
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CHAPTER III 
 
FRET STUDIES OF CRO VARIANT – DNA COMPLEXES: KINETICS 
AND EQUILIBRIUM 
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3.1 FLUORESCENCE RESONANCE ENERGY TRANSFER (FRET) 
 
FRET is the radiationless transmission of energy from a donor molecule to an acceptor 
molecule without emission of light. The donor is the dye that initially absorbs the energy, and the 
acceptor is the chromophore to which the energy is subsequently transferred (Van Der Meer, 
Coker et al., 1994). When they are dissociated, the donor emission is detected upon the donor 
excitation. When the donor and acceptor are in proximity (1–10 nm) due to the interaction of the 
two molecules, the acceptor emission is predominantly observed because of the intermolecular 
FRET from the donor to the acceptor. The sensitivity of fluorescence allows studies to be carried 
out at nanomolar or lower concentrations, which both minimizes the needed quantity of 
biomolecules and problems associated with aggregation and low solubility (Eftink 1998). FRET 
is highly efficient within the Förster radius (Ro) of the donor/acceptor pair (which is usually in 
the 50 – 60 Å range), making it useful over distances encountered within many biological 
macromolecules.  
FRET is a useful tool to investigate macromolecular interactions in general, and 
specifically protein-DNA interactions, for example. In studies with protein-DNA interactions, 
the fluorophores on proteins can be either intrinsic (tryptophan, tyrosine residues, coenzymes) or 
extrinsic (attached dansyl, fluorescein, pyrene) probes which can be covalently attached to either 
primary amino or thiol groups on the proteins. The thiol groups, which are present in cysteine 
residues in proteins, can conjugate to thiol reactive probes. Most of our fluorescence experiments 
are performed with the aid of the mutant proteins containing a cysteine residue. Once the 
fluorophores labeled protein and DNA are mixed, following excitation, energy can dissipate 
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from a donor dye to neighboring acceptor molecules. Nearby heterocyclic ring structure, as are 
present when the dye is conjugated to a nucleic acid or protein, will absorb some of this energy 
and quench the dye.  
Here we used 5-IAF (donor) to label the thiol groups of the cysteine residue in our FRET 
studies. Tetramethylrhodamine (acceptor) labeled DNA works as an acceptor. As one of the most 
commonly used donor/acceptor pair, the advantage of using IAF (donor)/tetramethylrhodamine 
(acceptor) is fluorescein‟s high extinction coefficient (81,000 M-1cm-1 at pH 9 and 61,000 M-
1
cm
-1
 at pH 7). The Ro for tetramethylrhodamine and IAF pair is 55 Å. Figure 3.1 shows the 
spectra of 5-IAF labeled protein and tetramethylrhodamine labeled OR3. 
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Figure 3.1 Fluorescence spectra of labeled protein and DNA 
 
Panel A shows the Excitation (dashed lines) and emission (solid lines) spectra of of 5-
IAF labeled Cro variants (green), rhodamine labeled OR3 (red). Same concentration (5nM) of 
dye labeled protein and OR3 were excited at their maximal absorbance for emission spectra or 
emitted at their maximal emission for excitation spectra. Fixed wavelengths for emission and 
excitation scans were 490 nm and 520 nm for Cro variants-5-IAF 555 nm and 585 nm for OR3-
rhodamine respectively. The spectra were normalized to the same scale.  
 
 Panel B is the energy transfer spectra (from a typical experiment) after excitation at 490 
nm, resulting in a decrease in donor (5-IAF), and an increase in acceptor (rhodamine) 
fluorescence. Emission spectra of separate samples 3nM Cro-5-IAF (solid blue line), 3nM OR3-
rhodamine (solid red line) and the complex (Cro-OR3, solid green line) are shown. Or3-
rhodamine has no contribution to the fluorescence at 520nm with excitation at 490nm. Emission 
spectra of equimolar equilibrium mixture of 5-IAF and rhodamine labeled OR3 is shown as a 
solid green line. 
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3.2 MATERIALS AND METHODS 
 
All experiments were carried out in KP200 buffer (20 mM potassium phosphate, 1 mM 
EDTA, and 1.4 mM 2-mercaptoethanol (βME), 100 μg/ml of bovine serum albumin (BSA, 
ordered from Sigma), 5% (v/v) glycerol, 200 mM potassium chloride at pH 7.0). Rhodamine 
labeled OR3R (3‟ TAMRA) and OR3F were purchased from integrated DNA technologies. 
Double strand OR3 was produced by hybridization of OR3R and OR3F. The 46 bp hairpin 
oligonucleotide (OR3HP) with the sequence of OR3 (5– TTTAT CCCTT GCGGT GATAA 
ATTTT TTTAT CACCG CAAGG GATAA A –3) was purchased from Trilink Biotech.  
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Table 3.1: Sequence of oligonucleotides 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Residue Sequence of Oligos 
OR3R 5‟-TTTATCACCGCAAGGGATAAA/36-TAMSp/-3‟ 
OR3F 5‟-TTTATCCCTTGCGGTGATAAA-3‟ 
OR3HP 
5– TTTAT CCCTT GCGGT GATAA ATTTT TTTAT 
CACCG CAAGG GATAA A –3 
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Figure 3.2 Diagrams of OR3 and OR3HP 
 
 
OR3R was labeled with tetramethylrhodamine at 3‟ (red color in figure). 
The 46 bp hairpin oligonucleotide (OR3HP) has the sequence of OR3. The complementary parts 
of the hairpin oligonucleotide were annealed with a temperature thermocycler by decreasing 1 °C 
per minute (1 cycle) from 95 °C to 4 °C in the buffer containing 10 mM Tris, 1mM EDTA, and 
50 mM NaCl (pH 8.0). 
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3.2.1 Kinetics Studies of Cro Variants- operator DNA Interactions 
3.2.1.1 Association rate constants (ka) of Cro variants-operator DNA 
interactions 
The decay of the fluorescence was monitored less than 1 second following the mixing of 
two reagents (scCro and OR3). Proteins and operator DNA were mixed by stopped-flow to 
measure the rate constant of the rapid reactions in solution (KP200 binding buffer).  
1nM Fluorescein-labeled Cro-variants were mixed with at least 10 fold amount of 
rhodamine-labeled operator DNA (OR3). Cro variant-DNA complexes were detected by energy 
transfer from fluorescein to rhodamine. The decrease in donor fluorescence was monitored after 
stopped-flow mixing. The reactions were treated as pseudo first order reactions and the 
association rate constants were obtained by fitting the curve to a single exponential function 
simulation in matlab.  
The rate constants were also measured as second order reactions by mixing same amount 
(much larger than Kd) of 5-IAF labeled scCro variants and rhodamine labeled operator NDA.  
The reaction can be expressed as below:  
As scCro variant and operator DNA are same amount, they disappear at the same rate and 
both are written as “A” in the equations. 
                                                (3.1) 
The rate of reaction, r, is given by 
   
 [ ]
  
   [ ]
                                          (3.2) 
Integrated the rate equation get 
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[ ]  
[  ]
    [  ] 
                                                         (   )   
The total fluorescence (Ft) can be expressed as 
       [ ]      ([  ]  [ ])                                    (3.4) 
Fmax is the fluorescence from scCro variant 
Fmin is the fluorescence from scCro variant-operator DNA complex 
The data were fit to equation (3.4) simulation in matlab (script “fitwl.m; second.m; 
seconddecreas.m” showed in Appendix c).  
Figure 3.3a and Figure 3.3b show the typical measurements of the ka of scCro binding to OR3 
and scCroPFPS-AWSG binding to OR3. 
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3.2.1.2 Dissociation rate constants (kd) of Cro variants-operator DNA 
interactions 
The dissociation rate constants of Cro variant–OR3 interactions were measured by 
fluorescence with manual or stopped-flow mixing. After 1nM of fluorescein-labeled Cro variants 
and same amount of rhodamine-labeled OR3 were mixed in the solution and equilibrated, 100 
fold excess of unlabeled OR3HP was added to the mixture to trap free Cro molecules. The 
kinetics of the irreversible dissociation process was monitored by fluorescence and the curve was 
fit to a single exponential function simulation in matlab (scripts “fitu.m; increase.m; singleex.m” 
showed in Appendix c). The average kd from 6 repeats including error estimates are given either 
in the text or in the tables as shown later. 
Figure 3.4a and Figure 3.4b show the measurements of the kd of scCro binding to OR3 
and scCroPFPS-AWSG binding to OR3. 
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3.2.2 Equilibrium analysis of Cro variants-operator DNA interactions  
3.2.2.1 Direct Titration Experiments of scCroPFP-AWG variant-DNA binding 
 
1nM fluoroscein labeled scCroPFP-AWG was titrated with rhodamine-labeled OR3 from 
0 to 30nM. Along with the formation of OR3-scCroPFP-AWG complex, FRET occurs. The 
decay of fluorescence at 520nm (Figure 3.1) was monitored by fluorometer. The 
experiments were repeated for 3 times. The average equilibrium constant (Kd = 1.2x10
-9
M, 
shown in Figure 3.5) was obtained by fitting the data to equation (5-7) (shown in appendix 
A) with Matlab (script “FF.m and CroDNAkdfit.m” shown in appendix c). 
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3.2.2.2 Competition Experiments (scCroPFPS-AWSG) 
Equilibrium competition experiments have been used to determine the operator DNA 
binding affinity of scCroPFPS-AWSG dimer relative to scCro dimer. A small amount of high 
concentration of unlabeled scCroPFPS-AWSG dimer was titrated into the mixture of equimolar pre-
equilibrated scCro-DNA complex. The increase of fluorescence intensity of scCro, when it was 
released from operator DNA by the competitive binding of engineered scCroPFPS-AWSG dimer, 
was monitored by excitation at 490 nm and emission 520 nm against the total concentration of 
engineered monomer. The experiments were repeated 3 times. 
Equilibrium dissociation constant (Kd = 0.9 x10
-9
M, showed in Figure 3.6) of scCroPFPS-
AWSG binding to OR3 can be obtained by fitting data to equation (5-14) with matlab script 
(smkdfit.m and Ff.m showed in appendix A) 
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3.2.2.3 Competition Experiments to obtain Kd of wtCro binding to OR3  
A small amount of high concentration of unlabeled wtCro(Q3C) was titrated into the 
mixture of equimolar (the concentrations for both are 3nM) pre-equilibrated scCro-DNA 
complex. The increase of fluorescence intensity of scCro, when it was released from operator 
DNA by the competitive binding of wtCro, was monitored by excitation at 490 nm and emission 
520 nm against the total concentration of Q3C. The experiment stopped when the intensity of 
fluorescence did not change after three more titrations. The experiments were repeated for 3 
times. 
The equilibrium dissociation constant of wild type Cro-operator DNA interaction can be 
estimated by the equation Kwt-obs = K1 K2 (shown in appendix A). 
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3.3 RESULTS 
3.3.1 scCro variants bind OR3 hundreds times faster than wild type Cro 
All experiments were carried out in KP200 buffer at 25
o
C. 
Figure 3.3 shows the association rate constants of scCro and scCroPFPS-AWSG binding to 
operator DNA (OR3). scCro variants eliminate the slow assembly process and show hundreds of 
times faster association (ka = (2.12 0.93) x 10
8
 M
-1
s
-1
 for scCro and (7.8 0.9) x 108 M-1s-1 for 
scCroPFPS-AWSG) with operator DNA (OR3) than wild type Cro.  
Figure 3.4: Dissociation rate constants of scCro variants binding to operator DNA (OR3). 
ScCro without one set of prolines dissociate hundreds of times faster than wild type Cro 
and scCro. (kd = 0.00582 s
-1
 for scCro and 1.13 s
-1
 for scCroPFPS-AWSG)  
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Figure 3.3: Association rate constants of scCro variants binding to operator DNA 
(OR3) 
 
Figures show the kinetic traces from typical experiments. 
 
Panel A: Association kinetics of scCro binding to operator DNA (OR3). 
The continuous lines represent theoretical fitting curves generated by fitting data to a single 
exponential equation and yield association rate constant ka = (2.12 ± 0.93) x 10
8
 M
-1
s
-1
. The 
value is the average of the results of 6 experiments. 
 
Panel B: Association kinetics of scCroPFPS-AWSG binding to operator DNA (OR3). 
The continuous lines represent theoretical fitting curves generated by fitting data to a single 
exponential equation and yield association rate constant  
ka = (7.8 ± 0.9) x 10
8
 M
-1
s
-1
. The value is the average of the results of 6 experiments. 
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Figure 3.4: Dissociation rate constants of scCro variants binding to operator DNA 
(OR3) 
 
Figures show the kinetic traces from typical experiments. 
 
Panel A: Dissociation kinetics of scCro binding to operator DNA (OR3). 
The continuous lines represent theoretical fitting curves generated by fitting data to a single 
exponential equation and yield association rate constant kd = (6.1 ± 0.62) x 10
-3
 s
-1
. 
The value is the average of the results of 6 experiments. 
 
Panel B: Dissociation kinetics of scCroPFPS-AWSG binding to operator DNA (OR3). 
The continuous lines represent theoretical fitting curves generated by fitting data to a single 
exponential equation and yield association rate constant kd = (1.06 ± 0.11) s
-1
. 
The value is the average of the results of 6 experiment 
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3.3.2 A single-chain Cro has near wild type Cro binding affinity  
Two methods, direct titration of 5-IAF labeled scCro variants with rhodamine labeled 
OR3 (OR3
-R
) and competition experiments, were used to measure the equilibrium dissociation 
constant of scCroPFPS-AWSG operator DNA interactions. All experiments were carried out in 
KP200 binding buffer at 25
0
C. Similar equilibrium dissociation constants (Kd ≈ 1nM), which is 
close to the binding affinity of wild type Cro to operator DNA (OR3), were obtained. Figure 3.5 
and Figure 3.6 showed the equilibrium dissociation constant (Kd) of scCroPFPS-AWSG binding 
operator DNA (OR3) by direct titration and competition method respectively. 
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Figure 3.5 Equilibrium dissociation constant (Kd) of scCroPFP-AWG binding to 
operator DNA (OR3) by direct titration 
Figure shows the fit of Kd from a typical experiment. 
 
Fluorescence at 520nm of fluorescein labeled scCroPFPS-AWSG with excitation at 490nm was 
plotted as a function of OR3
-R
 concentration. The concentration of scCroPFPS-AWSG was fixed at 
1nM and the concentration of OR3
-R
 was varied from 0nM to 30nM. The solid line is the fit of 
data to equation (2-7) and Kd = 0.84nM was obtained. The value is the average of the results of 3 
experiments. 
Inset Spectra shows the decrease of scCroPFPS-AWSG fluorescence as a function of OR3
-R
 
concentration. 
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Figure 3.6 Equilibrium dissociation constant (Kd) of scCroPFP-AWG binding operator 
DNA (OR3) by competition experiment 
Figure shows the fit of Kd from a typical experiment 
 The mixture of 1nM scCro
-IAF
 and 1nM OR3
-R
 was titrated by 0nM to 300nM scCroPFPS-AWSG. 
The solid line is the fitting of the fluorescence as a function of scCroPFPS-AWSG concentration to 
equation (2-14). Kd = 1.24nM was obtained. The value is the average of the results of 3 
experiments. 
(inset) Spectra shows the increase of scCro
-IAF
 fluorescence as a function of scCroPFPS-AWSG 
concentration. 
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3.4 DISCUSSION 
3.4.1 Labeling 5-IAF at the single cysteine has barely effect on DNA binding affinity 
Using fluorescence energy transfer, the parameters of scCro variants operator DNA 
interactions have been measured under native conditions. scCro variants operator DNA 
interactions were monitored by the change of donor fluorescence since almost all the 
fluorescence is from the 5-IAF at 520nm when it is excited at 490nm. The FRET method 
requires the reactants to be labeled with fluorescent probes (donor and acceptor pair). Several 
cysteine variants were constructed and used to study the folding and dimerization processes. 
Single cysteine variants of Cro were constructed by Jia et al., 2005 to identify surface exposed 
positions in the protein where fluorophores could be conjugated with minimal effects on protein 
structure, stability dimer assembly or DNA binding. Among the cysteine variants that best met 
those criteria is N-terminally extended protein that adds a His-6 purification tag and a unique 
cysteine residue to the unstructured N-terminus of Cro. Nhis-C3-scCroPFPS-AWSG was constructed 
by adding a single cysteine in a Histidine Tag (N-C3-(H)6): MGCS(H)6SSGL) at the unstructured 
N terminus of scCroPFPS-AWSG. This construction allows us to label the proteins with fluorescent 
probes (5-IAF) and employ the fluorescence resonance energy transfer (FRET) technique to 
characterize kinetic rates and equilibrium extent.  
The equilibrium of scCro variant binding to operator DNA was investigated by two 
methods: direct titration experiments and competition experiments. Direct titration experiments 
were carried out by titrating 1nM 5-IAF labeled scCroPFPS-AWSG with rhodamine labeled operator 
DNA with the range of 0-30nM. Competition experiment was performed by addition of 
unlabeled scCroPFPS-AWSG to the 5-IAF labeled scCro and rhodamine labeled operator DNA 
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complex. Although it is predicted that scCroPFPS-AWSG binds to operator DNA weaker than scCr, 
the presence of a large excess of unlabeled scCroPFPS-AWSG will replace almost all the scCro from 
the scCro-operator DNA complex and the process changed to the reaction between unlabeled 
scCroPFPS-AWSG with operator DNA. A Kd of 1.2nM was obtained by titration experiments and 
0.8nM from competition experiment. Agreement of the competition experiments and the direct 
titration experiments show that the label at the single cysteine has small if any effect on binding 
affinity. 
 
3.4.2 Proline residues replacement of scCro significantly accelerates the kinetics of the 
binding of wild type Cro for operator DNA 
At nanomolar concentrations that are typical for DNA binding most free wild type Cro 
subunits exist as isolated monomers. Cro monomer has to assemble first before binding to DNA. 
The slow assembly process takes hundreds of seconds which result in the slow association with 
operator DNA (ka ≈ 2 x 10
5
 M
-2
s
-1
). Proline isomerases can certainly accelerate Cro dimer 
assembly from the unfolded state in vitro (Satumba and Mossing 2002). Fluorescence and CD 
experiments have shown that Cro refolding from denatured states is limited by the slow trans  
cis isomerization at Pro 59 (Satumba and Mossing 2002; Al-Duraibi 2006). All Cro variants and 
conjugates have a similar slow folding rate of 0.006 s
-1
, a typical rate of proline isomerization 
(Reimer, Scherer et al,. 1981). All the peptide bonds in the Cro subunits are in the trans 
configuration except F58-P59. Slow phase is owing to the cis/trans isomerization of a prolyl 
bond to its native conformational state, a well-known phenomenon in the slow kinetic phases in 
the refolding of proteins (Brandta, Halvorson et al,. 1975; Ficher, Tradler et al,. 1998).  
  
73 
 
Single-chain Cro variants, constructed by connecting C-terminal of one subunit and N-
terminal of the next one with a short polypeptide linker (AGTGGSGG) (Jana, R; 1998), contain 
2 DNA-binding domains within a single polypeptide. Single-chain Cro enhances the stability and 
DNA binding affinity (Jana, R; 1998). ScCro variants eliminate the slow dimer assembly process 
and show hundreds of times faster association (ka = (2.12 0.93) x 10
8
 M
-1
s
-1
 for scCro and 
(7.8 0.9) x 108 M-1s-1 for scCroPFPS-AWSG as showed in Figure 3.3 with operator DNA (OR3) 
than wild type Cro. It takes about 10
3
 seconds for wild type Cro to associate with OR3 but less 
than 10 seconds for scCro dimers.  Refolding of scCro however is slow with a rate similar to the 
proline isomerization limited rates observed in the dimer and engineered monomer. It may worth 
to trade off some DNA binding affinity for a faster folding rate in scCro mutant. 
Any perturbation of the amino acid sequence of a protein can affect that protein„s 
stability. Residues of A52, E54, K56 and F58 close to the C-terminal part of the polypeptide 
chain are believed to have a significant role in maintaining the folded conformation of Cro dimer. 
Substitutions of two prolines (P57 and P59) of scCro result in the loss of the hydrophobic 
interactions between the proline ring and the aromatic residue (F58) in scCro. Kinetics studies 
indicate that the association and dissociation rate constants are both accelerated 3 orders of 
magnitudes. This result suggests that the distortion induced by the prolines replacement in this 
variant not only affects the stability but also the rate of assembly of the scCroPFPS-AWSG-operator 
complex. This interesting discovery prompted us to investigate the other physical properties of 
scCroPFPS-AWSG, like salt dependence and nonspecific DNA interactions.   
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Table 3.2 Kinetics and Equilibrium Constants of Cro Variants-Operator DNA Interactions 
in KP200 
The average values from 3 – 6 repeats including error estimates are given in the tables shown 
below. 
 
ka kd(s
-1
) Kd 
wtCro 2.1 ± (0.6)X10
5
(M
-2
s
-1
) 1.6 ± (0.46)X10
-4
 8.2 ± (0.9)X10
-10
(M
2
) 
scCro 2.12 ± (0.93)X10
9
(M
-1
s
-1
) 6.1 ± (0.62)X10
-4
 1.42 ± (0.57)X10
-11
(M) 
scCroPFPS-
AWSG 
7.8 ± (0.9)X10
8
(M
-1
s
-1
) 1.06 ± (0.11) 1.2 ± (0.7)X10
-9
(M) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
75 
 
3.4.3 Single-chain Cro variant has a close binding affinity to wild type Cro. 
 
The general prediction that prevention of dimer dissociation would enhance DNA 
binding affinity has been confirmed by linking two domains of several proteins. Some of these 
proteins are unfolded by themselves and bind to DNA only as a folded dimer (as in a designed 
single-chain Arc repressor). The linker can keep them as a folded dimer so that it is always 
DNA-binding-competent (Zhou, 2001). Single-chain Cro dimers such as scCro8 which the two 
subunits were connected by an 8 residue linker reduce the concentration of Cro subunits required 
for half saturation of an operator site by approximately 250-fold (Jana, 1998). Therefore the 
binding affinity for operator DNA was enhanced hundreds of times. The enhancement of affinity 
can be attributed almost entirely to an increased rate of Cro-DNA complex formation as the 
dissociation rate for the dimer-DNA complex is very similar to rate of the wild type Cro-DNA 
complex.  
As the substitution of prolines in scCro dimer leads to the loss of the stability of the 
scCro dimer due to the change at the interface of the Cro dimer. It turns out that scCroPFPS-AWSG 
accelerates not only the association rate but also the dissociation rate of the dimer-DNA complex. 
Therefore the binding affinity of scCroPFPS-AWSG to operator DNA is lower than scCro (Table 3.2) 
to the level that close to the affinity of wild type Cro operator DNA binding. Single-chain Cro 
variant prevents the dimer dissociation but does not enhance the binding affinity of wild type Cro. 
These interesting observations result in our subsequent investigations of the parameters of 
scCroPFPS-AWSG DNA interactions under other energetic driving forces to uncover the codes for 
efficient gene control.          
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CHAPTER IV 
COMPETITION FROM SMALL IONS AND NONSPECIFIC DNA 
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4.1 SINGLE-CHAIN CRO VARIANTS-NONSPECIFIC DNA INTERACTIONS 
4.1.1 INTRODUCTION 
Typical physical environment in vitro assay conditions is extremely different from the 
physical environment inside a cell. In addition to 6 primary sites for Cro binding in the lambda 
genome there are many alternative sites where weaker binding could occur.  The total length of 
the lambda genome is 48,502 nucleotide pairs [GenBank: J02459.1]. Inside an E. coli cell there 
are another 4.6 million base pairs of bacterial genomic DNA which compete with specific 
binding sites for the proteins involved in genetic regulation. As a result, although the binding of 
these proteins to nonspecific DNA is relatively weak, a large fraction of DNA-binding proteins is 
likely to bind to nonspecific sites. The binding specificity of a protein is determined by the 
difference in binding affinities of the protein for the specific versus the non-specific sites (Eric 
and Bustamante, 1994). Based on simple equilibrium consideration, specificity is defined in 
quantitative term as the ratio of the affinity of protein binding to operator sites (KOP) over the 
binding affinity of protein for non-specific DNA (KD), expressed as KD/KOP (Lin, s. and Riggs, 
A.D. 1975). KD/KOP =10
8
 was proposed for lac repressor on the assumption that E.coli can be 
considered as a uniform polymer with identical non-operator sites and every base pair is 
potentially the beginning of a binding site and the effective concentration of the “average” 
binding sites is just the concentration of base pairs in the DNA (Lin and Riggs. 1972),. Although 
the specificity of lac repressor for lac operator is very high, it is limited and it will be seen that 
the affinity for non-operator DNA has important consequences for in vivo regulation (Lin, s. and 
Riggs, A.D. 1975). 
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Calculations based on a thermodynamic analysis of lac repressor-operator interactions in 
E. coli indicate that a typical cell contains about nine repressor molecules bound to nonspecific 
sites, one repressor bound to the operator site, with much less than one repressor in a free state 
(Von Hippel et al., 1974). The ratio of the number of repressor molecules binding to nonspecific 
sites to specific sites indicates that non-specific DNA binding is crucial in controlling the 
concentration of free regulatory protein inside cell and consequently affects the cellular function.  
Here we characterized the binding affinity of wild type Cro and scCro variants for 
nonspecific DNA and compared the specificity of these Cro proteins binding to non-specific 
DNA over operator DNA. The ratios of numbers of Cro proteins binding to non-specific sites to 
the numbers binding to the specific sites (Nns/Ns) were also estimated.
 
As shown in the last chapter, scCro variants bind hundreds of times faster and more 
tightly to operator DNA than wild-type Cro as they eliminate the slow dimerization process. Do 
the scCro variants behave the similar way for nonspecific DNA interactions?  
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4.1.2 MATERIALS AND METHODS 
4.1.2.1 Buffers and Reagents 
 
KPL buffer contains 20 mM potassium phosphate, 2 M lysozyme (Sigma) at pH 7.0; 
KP20 buffer contains 20 mM potassium phosphate, 1mM EDTA, and 1.4 mM 2-
mercaptoethanol (ME) at pH 7.0; KP50, KP100 and KP 200 buffer is KP20 plus 50, 100 and 
200 mM potassium chloride respectively. For most experiments using KP20 and KP200 buffers, 
100 g/ml of bovine serum albumin (BSA, ordered from Sigma) and 5% (v/v) glycerol were also 
added for protein stability and fluorescence signal measurements.  All experiments were carried 
out at 25 °C unless otherwise indicated. Salmon sperm DNA (purchased from Qbiogene and 
prepared in TE buffer, pH 8.0.) was used as nonspecific DNA substrate in competition 
experiments. 
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4.1.2.2 Non-specific DNA Preparation 
               
122.5 mg dried salmon sperm DNA was weighed and cut with a scissors to small fibers. 
In a 50 ml Falcon tube, 20ml sterilized TE buffer was added to dissolve the fibers at 4°C 
overnight. The viscous dissolved salmon sperm DNA solution was sonicated at about 30% power 
for a minute at a time for about ten cycles until the solution becomes less viscous. Comparing 
with 2-log DNA ladder in 0.8% agarose gel, the size range of sonicated salmon sperm DNA was 
between 150bp and 2000bp.The concentration was 6.22mM(bp) measured by UV 
Spectrophotometry. The DNA solution was diluted to 100μM(bp) and dispensed in 1ml aliquots, 
and stored at -20°C for repeated usage. 
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4.1.2.3 Competition Experiments to Determine the Equilibrium Constants of 
scCro Variants-non-specific DNA Interactions 
Equimolar (2nM) pre-equilibrated scCro variants labeled with 5-IAF and operator 
DNA (OR3) labeled with rhodamine were mixed and equilibrated for about 15 minutes. A 
small amount of high concentration (1mM) of non-specific DNA (salmon sperm DNA, 
nsDNA) was added into the mixture solution. The intensity of the fluorescence increased as 
the release of scCro variants from operator DNA by the competitive binding of nsDNA. The 
titration was continued until no change of the intensity of the fluorescence was detected.  
Equilibrium constants of scCro variants-non-specific DNA interactions were estimated 
by equation (5-33) (showed in appendix A) when half of scCro variants was replaced in scCro 
variants-DNA complex (when θ = 1/2).  
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4.1.3 RESULTS 
4.1.3.1 Nonspecific DNA Binding Versus Specific DNA Binding 
Table 4-1 summarizes the equilibrium constants of scCro variants-DNA interactions 
specifically and nonspecifically. 
All the experiments were carried out in KP20 buffer containing 200mM KCl at 25
0
C. 
Equilibrium dissociation constants were calculated from equation (5-33) when operator DNA 
achieved half saturation. The binding affinities to nsDNA for wild type Cro and scCro variants 
are relatively weak comparing with operator DNA binding, the nsDNA interactions are over 10
5 
fold weaker than specific DNA binding for all three Cro proteins. The ratios of numbers of Cro 
proteins binding to non-specific sites to the numbers binding to the specific sites (Nns/Ns) are also 
showed in Table 4-1. 
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Table4-1 Equilibrium Dissociation Constants of Cro Variants- operator DNA            
and nonspecific DNA interactions in KP200 buffer 
 
 
 
 
 
 
 
 
 
 
 
  Equilibrium  
dissociation constant 
wtCro scCro scCroPFPS-AWSG 
Kd-s (M) 8.2 ± (0.9) x 10
 -10
(M
2
) 1.42 ± (0.57) x 10
 -11
 1.2 ± (0.7) x 10
-9
 
Kd-ns (M.bp) 1 x 10
-4
(M
2
.bp) 2.8 ± (1.1)x 10
-6
 3.8 ± (1.3) x 10
-4
 
Kd-ns/Kd-s 10
5
 2x10
5
 3x10
5
 
Nns/Ns 10 5 3 
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4.1.4 Discussion  
The interactions of scCro variants with non-specific DNA (salmon sperm DNA) have 
been investigated by competition experiments. 
Studies in vitro indicate that wild type Cro and scCro variants will bind nonspecifically to 
the E. coli chromosome in vivo. The non-specific DNA binding affinity is 10
-4
M for wild type 
Cro and scCroPFPS-AWSG and 10
-6
M for scCro. These non-specific DNA interactions with Cro 
proteins are significant. Here specificity is defined as Kd-ns/Kd-s. For the three Cro proteins, the 
specificities (Kd-ns/Kd-s) are about 10
5
. In E.coli cell there is about a 10
6 
fold excess of non-
specific DNA binding sites over operator DNA binding sites. The ratios of numbers of Cro 
proteins binding to non-specific sites to the numbers binding to the specific sites (Nns/Ns) showed 
in Table 4-1 indicates that Nns/Ns is 10 for wild type Cro while 5 for scCro and 3 for scCroPFPS-
AWSG. These numbers agree with the values estimated by Bakk and Metzler (2004) that 86% of 
the total number of CI repressors is nonspecifically bound. Although the specific DNA binding 
shows extremely higher affinity than nonspecific DNA binding, the presence of overwhelming 
preponderance of nonspecific DNA binding sites trap more protein molecules than operator 
binding sites. A large number of low affinity sites will compete just as well as a small number of 
high affinity sites (Lin and Riggs, 1975). From Table 4-1 it seems that a slightly bigger 
proportion of wild type Cro molecules binding to nonspecific DNA Than scCro variants. This 
result may be explained by that the presence of plenty of non-operator DNA results in faster 
formation of Cro monomerDNA complex, which is followed by recruitment of the second 
monomer to form the final complex (Jia, Satumba et al. 2005). 
  
85 
 
Under the assumption that the repressor([RT]) is in large excess over the operator([OT]) 
and [RT]>> KOP (the affinity of repressor binding to operator sites) and non-operator DNA [DT]>> 
KD (binding affinity of repressor for non-specific DNA), the efficiency of repressor binds to the 
operator can be determined by the ratios of KD/KOP and the ratio of RT/DT, expressed as 
[ ] [  ]     [  ]   [  ]⁄⁄ (KOP and KD are dissociation constants of repressor binding to 
operator sites and non-operator sites respectively) (Ptashne, 2004). By applying this general 
rule, we estimate that about [ ]         ⁄  in vitro which are close to the values estimated by 
Kao-Huang et al. (1977) that [ ]      
   ⁄  as KRD(association constant) in vivo are at least 
10
3
M
-1
 and correspondingly in vivo value of KRO(association constant)  must at least 10
12
M
-1
. 
Wild type Cro and scCroPFPS-AWSG bind to nonspecific DNA much weaker  
(Kd-ns ≈ 10
-4
 M) than scCro which can be account for the less stability of wild type Cro 
and scCroPFPS-AWSG than scCro. Comparison of the equilibrium dissociation constants of 
scCroPFPS-AWSG and wild type Cro for nonspecific DNA shows that scCroPFPS-AWSG has close 
binding affinity to wild type Cro not only for specific DNA but also for non-specific DNA.  
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4.2 EFFECTS OF KCL ON SINGLE-CHAIN CRO VARIANTS DNA INTERACTIONS 
4.2.1 INTRODUCTION 
Subsequent investigations have probed the role of other energetic driving forces (salt 
concentration, pH, T) in an effort to uncover the codes for efficient gene control (Koblan & 
Ackers, 1991, 1992; Senear & Ackers, 1990). Electrostatics plays an important role in the 
stability of proteins and protein-DNA interactions because at a thermodynamic level, protein-
nucleic acid interactions may be modeled as ion-exchange reactions, in which the neutralization 
of polyelectrolyte charge that occurs upon forming the noncovalent complex is accompanied by 
the release of large numbers of electrolyte ions to the bulk solution: protein + nucleic acid ↔ 
complex + n ions, where typically n >> 1 (Record et al., 1976, 1978, 1985). Consequently, the 
equilibrium extent of interaction is a sensitive function of the bulk salt concentration. Cro is a 
highly positively charged molecule (+6 per subunit at neutral pH) with pI of 9.9. Thus the 
electrostatic effects play a significant role in the interactions between Cro repressor and DNA.  
The in vitro sensitivity of protein-DNA interactions to the nature and the concentration 
electrolyte ions (effects which are species-specific and not ionic strength effects) suggests that 
protein-DNA interactions should be affected by the same variables in vivo. Given the sensitivity 
of protein-DNA interactions to electrolyte activity observed in vitro and the variability of the 
intracellular ionic environment, it is important to quantify the changes that occur in the activities 
of intracellular electrolyte ions and the possible effects of these variations on protein-DNA 
interactions in vivo. In vitro studies of specific and nonspecific protein-DNA interactions 
invariably show that both the equilibrium stability of the complex and the kinetics of its 
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formation and dissociation are strongly dependent on the activities and types of the 
accompanying electrolyte ions. 
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4.2.2 MATERIALS AND METHODS 
Salt dependence experiments were performed in an Mg
2+ 
free buffer containing 0.02 M 
potassium phosphate (pH adjusted to 7 at 25 
0
C with HCl), 0.05-0.20 M KCl, 100 mg/ml of BSA 
and 5% (v/v) glycerol.  
In the kinetics studies, association kinetic experiments were performed by mixing same 
amount of fluorescein-labeled Cro variants with rhodamine labeled OR3 in the KP20 buffer 
containing different concentrations of KCl. Cro variants-DNA complexes were detected via 
energy transfer from fluorescein to rhodamine. The decrease in donor fluorescence was 
monitored after stopped-flow mixing and the association rate constant was obtained by fitting the 
curve to a single exponential function. For the dissociation rate constants salt dependence 
experiments, after same amount of fluorescein-labeled Cro variants and rhodamine-labeled OR3 
were mixed and equilibrated for 15 minutes, 100 fold excess of unlabeled OR3HP was added to 
the mixture to trap free repressor molecules. The kinetics of the irreversible dissociation process 
was monitored immediately. The increase of fluorescence observed with 490 nm excitation and 
520 nm emissions was monitored by fluorometer or stopped-flow and the data was fit to a single 
exponential function to obtain the rate constant. The average of rate constants from 6 repeats 
including error estimates are given either in the text or in the tables as shown later. 
In the equilibrium studies, the equilibrium dissociation constants can be obtained by 
calculations of the ratio of dissociation rate constant to association rate constants in different salt 
concentration buffers or by direct titration and competition experiments. 
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4.2.3 RESULTS 
4.2.3.1 [K+] effects on scCro-DNA Interactions 
4.2.3.1.1 Kinetics of scCro-DNA Interactions on [K+] 
Table 4-2, Figure 4.5 and 4.6 summarize the [K
+
] effects on the kinetics of scCro-DNA 
interaction. The association of scCro dimer with operator DNA shows no dependence on salt 
concentration in the range (0.05-0.2M KCl) investigated. The dissociation of scCro dimer with 
operator DNA shows moderate dependence on salt concentration in the range (0.05-0.2M KCl) 
investigated. Dissociation rate constant increases by 2 orders of magnitude over this range. 
Figure4.5 and 4.6 show the plots of logarithm of ka and kd of scCro-operator DNA as a function 
of the logarithm of the [K
+
]. The slope of the log-log plot of kdsc vs. [K
+
] is 3.2, indicating that 
the net uptake of the thermodynamic equivalent of approximately 3 ions occurs prior to or as part 
of the rate-limiting step of the dissociation reaction (Roe et al., 1984; Lohman et al., 1978). 
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Table 4-2 [K
+
] effects on the kinetics of scCro-operator DNA interactions 
[K
+
] (M) ka-sc (M
-1
s
-1
) kd-sc (s
-1
) 
0.05 1.15 ± (0.53) x 10
9
 7.32 ± (0.53)  x 10
-5
 
0.1 1.25 ±  (0.35) x 10
9
 9.4 ± (0.5) x 10
-4
 
0.2 2.12 ± (0.93) x 10
9
 6.1 ± (0.62) x 10
-3
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4.2.3.1.2 Equilibrium constant (Kd) of scCro-DNA interactions on [K+] 
Table 4-3 and Figure 4.1 show the [K
+
] effects on the equilibrium constant of scCro-DNA 
interaction. We observed a moderate effect of [K
+
] on the equilibrium constant of scCro-operator 
DNA interaction. Kd increases by 2 orders of magnitude over the salt range investigated. The 
log-log plot of Kd versus [K
+
] in Figure 4.2 gives a slope of 4 which indicates that the ion-
exchange stoichiometry for the overall binding process in KCl is approximately 4: 
scCro + operator DNA (OR3) ↔ complex + 4 monovalent ions  
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Table 4-3. [K+] effects on the equilibrium constant of scCro-operator DNA 
interactions 
[K
+
] (M) Kd-sc (M) 
0.05 6.35 ± (1.1) x 10
-14
 
0.1 8.70 ± (0.90) x 10
-13
 
0.2 1.42 ± (0.57) x 10
-11
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Figure 4.1 Dependence of equilibrium constants of scCro-operator DNA on [K+] 
The solid line is the linear fit to the data: 
 (       )  (    [ 
 ])⁄      
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4.2.3.2 Effects of [K+] on scCroPFPS-AWSG -DNA interaction 
4.2.3.2.1 Kinetics of scCroPFPS-AWSG-DNA interactions on [K
+] 
Table 4-4 and Figure 4.5 and 4.6 summarize the [K
+
] effects on the kinetics of scCroPFPS-AWSG 
specific DNA interaction. The association of scCroPFPS-AWSG with operator DNA shows no 
evident dependence on salt concentration in the range (0.05-0.2M KCl) investigated. The 
dissociation of scCroPFPS-AWSG with operator DNA shows moderate dependence on salt 
concentration in the range (0.05-0.2M KCl) investigated. kd increases by 3 orders of magnitude 
over this range. Figure4.5 and 4.6 show the plots of logarithm of ka and kd of scCroPFPS-AWSG -
operator DNA as a function of the logarithm of the [K
+
]. The slope of the log-log plot of 
kd(scCroPFPS-AWSG) vs. [K
+
] is 4.8, indicating that the net uptake of the thermodynamic equivalent 
of approximately 5 ions occurs prior to or as part of the rate-limiting step of the dissociation 
reaction. 
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Figure 4.2 [K+] effect on observed dissociation of scCroPFPS-AWSG-operator 
complex 
The increase in fluorescence observed with 490 nm excitation and 520 nm emissions due to 
energy transfer is plotted vs. time for equimolar mixtures of fluorescein labeled scCroPFPS-AWSG 
and rhodamine labeled operator DNA. 
As the salt concentration increased from 50mM KCl to 100mM KCl and finally 200mM KCl, the 
scCroPFPS-AWSG -operator DNA complex dissociation half-life decreased from 3000seconds to 
10seconds and the extent of binding decreased as well. 
 (inset) Shows the amplification of the bigger graph from 0 to 60seconds. 
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Table 4-4: Effect of [K+] on the kinetics of scCroPFPS-AWSG specific DNA binding 
 
[K
+
] (M) ka(scCroPFPS-AWSG) (M
-1
s
-1
)  kd(scCroPFPS-AWSG) (s
-1
) 
0.05 2.43 ± (1.0) x 10
8
 1.38 ± (0.23) x 10
-3
 
0.1 3.02 ± (0.93) x 10
8
 3.02 ± (0.28) x 10
-2
 
0.2 7.8 ± (0.9) x 10
8
 1.06 ± 0.11 
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4.2.3.2.2 Equilibrium constant (Kd) of scCroPFP-AWG specific DNA interaction 
on [K+] 
Table 4-5 and figure 4.3 show the [K
+
] effects on the equilibrium constant of scCroPFPS-AWSG 
specific DNA interaction. We observed a moderate effect of [K
+
] on the equilibrium constant of 
scCroPFPS-AWSG-operator DNA interaction. Kd increases by 3 orders of magnitude over the salt 
range investigated. The log-log plot of Kd versus [K
+
] in figure 4.4 gives a slope of 3.8 which 
indicates that the ion-exchange stoichiometry for the overall binding process in KCl is 
approximately 4: 
scCroPFPS-AWSG + operator DNA (OR3) ↔ complex + 4 monovalent ions  
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Table 4-5. [K+] effects on the equilibrium constant of scCroPFPS-AWSG-operator DNA 
interactions 
 
[K
+
] (M) Kd-scCroPFPS-AWSG (M) 
0.05 6.30 ± (1.3) x 10
-12
 
0.1 8.50 ± (1.6) x 10
-11
 
0.2 1.2 ±  (0.70) x 10
-9
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Figure 4.3 Dependence of equilibrium constant of scCroPFPS-AWSG -operator DNA 
on [K+] 
The solid line is the linear fit to the data:  (                )  (    [ 
 ])⁄     . 
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4.2.3.3 ScCro variants –nonspecific DNA binding on [K+] 
 
Table 4.6 and Figure 4.4 show the equilibrium constants of scCro variants-nonspecific 
DNA interaction on [K+]. The values are the average of 3 repeats including error estimates. 
The interaction of scCro with nonspecific DNA is slightly dependent on [K+]. Kd 
decreases by 2 orders of magnitude from 0.05 M KCl to 0.2 M KCl. From a plot of log Kd vs. log 
[K+] in Figure 4.4, it is apparent that the ion-exchange stoichiometry for the overall process of 
open complex formation at scCro in KCl is approximately 3. 
The interaction of scCroPFPS-AWSG with nonspecific DNA has a stronger dependence on 
[K+]. Kd decreases by 5 orders of magnitude from 0.05 M KCl to 0.2 M KCl. The log-log plot of 
Kd vs. [K
+] in Figure 4.4 gives a slope of 8.8 which indicates that the ion-exchange 
stoichiometry for the overall process of open complex in KCl is approximately 9. scCroPFPS-AWSG 
+ nonspecific DNA ↔ scCroPFPS-AWSG -nsDNA + 9 ions 
  
 
 
 
 
 
 
 
 
  
101 
 
Table 4-6 Equilibrium dissociation constants of sc Cro variants non-specific DNA binding 
on [K
+
] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[K+] 0.05M 0.1M 0.2M 
K
sc-ns 
(M.bp) 3.2 ± (1.8) x 10-8 5.8 ± (1.4)  x 10-7 2.8 ± (1.1) x 10-6 
KscCro PFPS-AWSG-ns (M.bp) 1.9 ± (1.6) x 10
-8 2.1 ± (1.7)  x 10-6 3.75 ± (1.3) x 10-4 
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Figure 4.4 Effect of [K+] on equilibrium dissociation constant of scCro variants 
non-specific DNA binding 
The solid lines are the linear fits to the data: 
 (          )  (    [ 
 ])⁄     ;  (                   )  (    [ 
 ])⁄      
 
 
 
 
 
 
 
 
 
-10
-9
-8
-7
-6
-5
-4
-3
-2
-1.5 -1.3 -1.1 -0.9 -0.7 -0.5
L
o
g
 (
K
n
s)
 
Log (K+) 
Ksc-ns
Ksc(-2p)-ns
  
103 
 
4.2.4 DISCUSSION 
4.2.4.1 Similar Salt Dependence on scCro Varants Specific DNA binding 
Numerous physical and chemical variables act to affect the physiological behaviors of the 
biological circuits. In particular, noncovalent interactions are responsible for both the stability 
and the specificity of assembly of the protein-DNA complexex involved in gene expresson and 
its controling (Record, ). The dominant noncovalent forces for macromolecular interactions 
hydrophobic effect, polyelectrolyte effect.  In addition to the main function of hydrogen bond 
and hydrophobic interactions in assembly of Cro protein–operator DNA complex, the ion 
exchange also play an important role. The large effects of ion concentrations have been observe 
on the rate of open complex formation between RNA polymerase and the XPR promoter and  are 
a dominant characteristic of the kinetics and equilibria of protein-nucleic acid interactions and 
nucleic acid conformational equilibria (Roe and Record, 1985). 
Determination of the behavior of equilibrium dissociation constant as a function of 
solution variables, like salt concentration, is necessary in order to understand the contributions of 
ionic and other noncovalent interactions to the overall binding free energy under specified 
conditions. Here we studied the effect of small cation (K
+
) on the kinetics and equilibrium 
constant of Cro variants DNA binding specifically and nonspecifically. The assembly of scCro 
variants with operator DNA did not show significant dependence on salt concentration in the 
range investigated. The dissociation  process of  scCro variants operator DNA complex becomes 
faster from hour orders to a few seconds as the salt concentration increases. Figure 3.5 shows the 
increase of relative fluorescence, as dissociation of scCroPFPS-AWSG -operator DNA occurs, versus 
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time under different [K
+
]. This result suggests that the stability of the complex decrease with the 
[K
+
] increase from 0.05M to 0.2M.  
Lambda regulatory protein Cro variants carry 6 net positive charge  per unit around their 
binding site. DNA is a polyelectrolyte. The high charge density of the 
phosphodiester backbone results in condensation of counterions to neutralize the bulk of the 
charge on the phosphates. The polyelectrolyte effect in the reaction of Cro vriants and DNA 
arises from tighly bound counterions that are displaced during the formation of complexes. The 
formation of the Cro variants-DNA is accompanied the release of cations into the solution. The 
salt effect on the equilibrium dissociation constant indicates that every molecule of scCro 
variant-operator DNA assembly will release about 4 ions into solution. The specific DNA 
binding by scCro repressor involves about 4 charge-charge interactions. 
The kinetics of scCro variants-operator DNA interactions on [K
+
] indicates that the 
dependence of the equilibrium constant on the 4th power of the salt concentration is almost 
entirely contributed by dissociation rate constant. Contrast the effect of [K
+
] on the equilibrium 
dissociation constant (Kd) of scCro variants operator DNA interactions to wild type (Q3C) Cro–
operator DNA binding showed in Table 4-7 and Figure 4.6, similar salt dependence observed.  
For a typical reaction of scCro variants DNA interactions the rate of association is propotial to 
the concentration of the free scCro molecules and free DNA molecules while rate of dissociation 
is related to the concentration of scCro-DNA complex and 4 power of cation concentration. As 
an reactant in the dissociation process of the complex, cation affect the interaction of scCro 
variant and DNA mainly on the disassembly of the complex. 
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Figure 4.5 Dependence of Association Kinetics of scCro Variants-OR3 on [K
+] 
The solid lines are linear fits to the data:  (       )  (    [ 
 ])⁄     ; 
 (                 )  (    [ 
 ])⁄      
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Figure 4.6 Dependence of Dissociation Kinetics of scCro Variants - OR3 on [K
+] 
The solid lines are linear fits to the data:  
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 ])⁄     ;   (                 )  (    [ 
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Table 4-7. Dependence of  Equilibrium Constants of Cro Variants-
operator DNA interactions on [K+]  
 [K
+
] (M) Kd-Q3C Kd-scPFPS-AWSG (M) Kd-sc (M) 
0.05 2.96 ± (1.4) x 10
-12
(M
2
) 6.30 ± (1.3) x 10
-12
 6.35 ± (1.1) x 10
-14
 
0.1 4.06 ± (1.1) x 10
-11
(M
2
) 8.50 ± (1.6) x 10
-11
 8.70 ± (0.90) x 10
-13
 
0.2 8.2 ± (0.9) x 10
 -10
(M
2
) 1.2 ± (0.70) x 10
-9
 1.42 ± (0.57) x 10
-11
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4.2.4.2 Different salt sensitivity of scCro variants nonspecific binding 
A variety of physiological and genetic conditions should be taken into account in the vitro 
experiments in order to apply the physical parameters obtained in vitro experiments on predicting 
the outcome of the vivo investigations. Small ions are one of the most important components 
affecting the regulatory protein-DNA interactions which control gene expression. 
Non-specific DNA bind of lac repressor is thought to involve primarily interactions of 
DNA phosphate groups with cationic groups on lac repressor, accompanied by displacement of a 
large number of cations from the DNA (Ha et al, 1992). Record and his coworkers also showed 
that nonspecific binding of proteins to DNA is purely electrostatic and can be quantitatively 
explained in terms of competitive condensed counterion displacement from the DNA by 
polycationic proteins. 
Here we studied [K+] effects on scCro nonspecific binding by competition experiments. 
Our calculations by fitting data to equation (4-10), based on simple equilibrium considerations, 
imply that salt dependencies of specific and nonspecific binding are nearly identical for scCro 
(log-log plots of Kdsc and Kdsc-ns vs [K
+] give a slope of 4) but drastically different for scCroPFPS-
AWSG where the log-log plots of Kdsc- PFPS-AWSG and Kdsc-PFPS-AWSG-ns vs [K
+] give slopes of 4 and 9 
respectively. Approximately nine charge-charge interactions occurred in the formation of 
scCroPFPS-AWSG repressor-non-specific DNA complex. The difference of salt sensitivities between 
non-specifically binding of scCro and scCroPFPS-AWSG probably due to the less stable structure of 
scCroPFPS-AWSG compared to scCro. scCro was shown to enhance thermal stability of wild type 
Cro. The more stable scCro binds to operator DNA and non-operator DNA with similar interface. 
Similar amount of cations were replaced by the polycationic protein. scCroPFPS-AWSG has a more 
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loose structure than scCro. A larger binding interface between non-specific DNA and scCroPFPS-
AWSG may be formed when they assemble. Therefore more surface of the non-specific DNA was 
involved in the reaction and more cations were  thus released to the solution. Comparison of the 
KCl effects on binding to the operator sites of OR3 and to non-specific DNA shows apparent 
differences in the slopes of log-log plots (Figures 4.3 and 4.4). These slopes reflect about 9 
counterions removal from the DNA upon scCroPFPS-AWSG binding. The result is supported by 
Takeda et al. that showed the analysis of the ionic-strength dependence of nonspecific Cro-DNA 
association by an electrostatic model (Manning et al. 1978, Record et al. 1978) suggested the 
release of about nine univalent cations. This result suggests that scCroPFPS-AWSG-nonspecific DNA 
interaction is predominantly electrostatic. Given the magnitude of these ion effects and the 
variability of the intracellular ionic environment, it is clear that these changes in vivo ion 
concentrations must play a global regulatory role in the initiation of transcription and on 
numerous other steps in gene expression. 
On and off of genes is controlled by the binding of regulatory proteins for specific DNA. 
The phage lambda can switch from one state (lysogeny) to another (lytic growth) in response to 
an external signal (Johnson et al. 1981). To understand the physical principles that govern the 
ways in which the protein-DNA and protein-protein interactions operate in concert to produce 
the known physiological behavior many models of dimers assembly and repressor DNA 
complexes were proposed out. Model based on statistical thermodynamic assumptions is thought 
sufficient to account for some of the known physiological properties of the repressor-operator 
regulatory system (Ackers et al. 1981). According to the principles of the statistical 
thermodynamic model that the physiological behavior of genetic system is governed by 
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thermodynamic energies which are related to binding affinities, we can imagine that same 
concentration proteins with the same binding affinities for DNA will function similar in the 
model. We think the kinetics mechanism is also important in controlling the physiological 
behavior of the genetic switch.  
Our goal going to this dissertation is the construction of a protein which can separate the 
kinetics from thermodynamics by eliminating the slow assembly process. Kinetic and 
equilibrium extent studies in this dissertation showed that the engineered scCro has a similar 
binding profile to wild type Cro except that hundreds of times faster kinetics. Under the premise 
of the statistic thermodynamic models if we replace wild type Cro with scCroPFPS-AWSG it will not 
affect the physiological behavior of the switch since they have a similar binding affinity. The 
selection of lytic or lysogenic life cycles by the lambda genetic switch lies on the winner of the 
competition between the two regulatory repressor: CI and Cro. The relative slow folding and 
association of Cro subunits puts Cro at a disadvantage. Single-chian Cro variant eliminates the 
slow dimerization process and may consequently change the outcome of the switch. The 
predicted properties in vitro will be compared with those observed in vivo and the assumption 
will be evaluated in vivo. 
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5.1.1 Direct Titration Experiments of scCroPFP-AWG variant-DNA binding 
From the spectra of labeled protein and labeled OR3 (Figure2.1) we can see that rhodamine has a 
very small contribution to the fluorescence at 520nm after excitation at 490nm. The fluorescence 
arose almost completely from fluorescein labeled proteins.  
 Let M = scCroPFP-AWG and O = operator DNA, there is 
Ft(520nm)  =  FM(520nm)  [M] + FMO(520nm)  [MO]                                                                  (5-1) 
Where Ft(520nm)  is the total fluorescence  
                 FM(520nm)  is the contribution of fluorescence from donor [M] 
           FMO(520nm)  is the contribution of fluorescence from complex [MO] 
           [M] is the concentration of protein labeled with donor dye 
           [MO] is the concentration of protein-DNA complex 
For the reaction   
  
↔              [ ]  [  ]  [  ]     [ ]  [  ]  [  ].         
    
[ ][ ]
[  ]
 
    
([  ]  [  ])([  ]  [  ])
[  ]
    
   
[  ]  ([  ]  [  ])[  ]  [  ][  ]
[  ]
                                                      (   ) 
Rearranging quadratic gives [  ]  (   [  ]  [  ])[  ]  [  ][  ]      
Solving the quadratic gives       
 [  ]  
  √    [  ][  ]
 
      [  ]  [  ]                                                     (   )   
[ ]  [  ]  [  ]  [  ]  
  √    [  ][  ]
 
                                                   (   )                                                  
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Substituting [M] and [MO] in equation (5-1) with equation (5-3) and equation (5-4) gives 
 
 
  (     )  
  (     ) ([  ]  
  √    [  ][  ]
 
)     (     ) (
  √    [  ][  ]
 
 )           (   )    
 
Direct titration experiments to get the equilibrium dissociation constant were carried out by 
titrating a small amount of protein ([M]) with excess of DNA ([O]) (from 0nM to 30nM). Before 
titration, FD(520nm) = Fmax / [Mt]. At the end of titration, almost all the protein binds to DNA ([M] 
<< [MO]) and FMO(520nm)  = Fmin / [Mt].  
Equation (5-5) can be written as below:  
  (     )  
    
[  ]
([  ]   
  √    [  ][  ]
 
 )  
    
[  ]
( 
  √    [  ][  ]
 
 )            (   )                   
Rearranging equation (6) gives 
 
  (     )       (
         
[  ]
) ( 
  √    [  ][  ]
 
 )                                              (   )                                                 
 
 
 
 
 
 
 
 
 
 
  
127 
 
5.1.2 Competition experiment to obtain Kd of scCroPFPS-AWSG binding to OR3 
In the competition experiments, there are two binding reactions proceed. 
(Given C = scCro, M = scCroPFPS-AWSG, O = operator DNA) 
C + O ↔ CO 
M + O↔ MO 
The mass-action equations describing these reactions are (Kc, dissociation equilibrium 
constant of scCro-OR3 interactions; Km, dissociation equilibrium constant of scCroPFP-AWG -
OR3 interactions): 
   
([  ]  [  ])([  ]  [  ]  [  ])
[  ]
                                                                 (   ) 
   
([  ]  [  ])([  ]  [  ]  [  ])
[  ]
                                                              (   ) 
Combining equation (5-8) and equation (5-9) gives  
 
[  ]  
([  ]  [  ])[  ]
  (  
[  ]  [  ]
  
)  ([  ]  [  ])
                                                        (    )  
 
 
 
 
In the competition experiments, M>>MO, so we assume that Mt – MO ≈ Mt. 
 
Rearranging equation (5-10) and Ө = [CO] /[Ct] gives 
 
  
(   )[  ]
  (  
[  ]
  
)  [  ](   )
                                                                                   (    ) 
                                                                                                                     
Solving the quadratic equation (5-11) gives                                                                             
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  √    [  ][  ]
 [  ]
   [  ]     
[  ]  
  
 [  ]                                     (    ) 
 
The contributions of the fluorescence signal are from free scCro and scCro-DNA complex. 
 
Ft(520nm)  =  Fsc(520nm)  [C] + Fsc-DNA(520nm)  [CO]                                                          
 
Ft(520nm)  =  Fsc(520nm)  ([Ct] – [CO]) + Fsc-DNA(520nm)  [CO]                                     (5-13)                                                
 
Substitute CO with Ө = [CO]/[Ct] and rearranging equation (2-6) gives 
 
Ft(520nm)  =  Fsc(520nm)  [Ct] – (Fsc(520nm)  - Fsc-DNA(520nm)  ) [Ct] Ө                                 (5-14) 
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5.1.3 Competition experiment to obtain Kd of wtCro binding to OR3 
The competition experiment for wild type Cro replacing scCro in scCro-operator DNA 
complex is similar to the competition experiments for scCroPFPS-AWSG except that there are 
three reactions in the solution.  
(Given C = scCro; M = wtCro; O = operator DNA; K1, K2, K3 are equilibrium dissociation 
constants for wild type Cro dimerization, wild type Cro dimer-operator DNA interaction and 
scCro-operator DNA binding ) 
M + M ↔ M2 
M2 + O ↔ M2O 
C + O ↔ CO 
   
[ ][ ]
[  ]
    
[  ][ ]
[   ]
     
[ ][ ]
[  ]
                                                            (    ) 
The distributions and relationship of three reactants in the solution are:  
[  ]  [ ]   [  ]   [   ]                                                                                   (    ) 
[  ]  [   ]  [  ]  [ ]                                                                                          (    ) 
[  ]  [ ]  [  ]                                                                                                            (    ) 
As Ө = [CO] / [Ct], [CO] = [Ct] Ө and [C ]= [Ct] (1- Ө).                                   (    ) 
Substituting [C] and [CO] in equation (5-15) for K3 with equation (5-19) gives  
[ ]  
   
   
                                                                                                                      (    ) 
Replacing [O], [CO] in equation (5-17) gets 
[   ]  [  ]  [  ]  
   
   
                                                                                      (    ) 
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Combining K1 in equation (5-15), equation (5-20) and equation (5-21) gives 
[ ]  
    √  
      
 
   [  ]   [  ](   )                                            (    ) 
 The assumption of this experiment is that [Ot] = [Ct].  
When [C] achieves half saturation, Ө = ½, [O] = K3, B = [Mt] – [Ct]. 
   
 [ ]   
  ([  ]     )
                                                                                                          (    ) 
For the overall reaction of wild type Cro operator DNA binding, there is  
     
       
↔          Kwt-obs is the apparent equilibrium dissociation constant. 
        
[ ] [ ]
[   ]
 
 
Combining K1, K2 in equation (5-15) and K wt-obs gives K wt-obs = K1 K2. 
Given K1 obtained from previous studies in our lab and K2 calculated from equation (5-23), the 
equilibrium dissociation constant of wild type Cro-operator DNA interaction can be estimated by 
the equation K wt-obs = K1 K2.  
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5.1.4 Competition Experiments to Determine the Equilibrium Constants of scCro 
Variants-Non-specific DNA Interactions 
               In these competition experiments, there are two binding reactions proceed. 
(Given C = scCro variant; N = non-specific DNA (ns DNA); O = operator DNA(OR3)) 
C + O ↔ CO 
C + N ↔ CN 
The mass-action equations describing these reactions are (K, dissociation equilibrium constant 
of scCro-OR3 interactions; Kn, dissociation equilibrium constant of scCro-nsDNA 
interactions): 
  
[ ][ ]
[  ]
                                                                                                                      (    ) 
   
[ ][ ]
[  ]
                                                                                                                    (    ) 
The distribution of the species in the solution can be expressed as: 
[  ]  [ ]  [  ]  [  ]                                                                                              (    ) 
[  ]  [ ]  [  ]                                                                                                            (    ) 
[  ]  [ ]  [  ]                                                                                                            (    ) 
Ɵ represents the fraction of specific DNA binding. 
  
[  ]
[  ]  [  ]
                                                                                                                  (    ) 
Rearranging equation (5-29) and combining equation (5-28) gives 
[  ]  [  ]   [ ]  [  ](   )                                                                                 (    ) 
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Substituting [CO] and [O] in equation (5-24) gives 
[ ]   
 
   
                                                                                                                     (    )   
Replacing [C] and [CO] in equation (5-26) with Equation (5-30) and Equation (5-31) gives 
[  ]  [  ](   )   
 
   
   [  ]  [  ]                                                               (    ) 
Replacing [CN] in equation (5-28) by Equation (5-32) gives 
[ ]  [  ]  [  ](   )   
 
   
  
 Substituting [N], [C] and [CN] in equation (5-25) gets 
   
  
   {
[  ]  [  ](   )  
  
   }
[  ](   )  
  
   
                                                                 (    ) 
Kn can be estimated from equation (5-33) and the midpoint of scCro variants specific DNA 
interactions titration. 
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This appendix contains several programs used in this dissertation to fit the experiment 
data or simulate some models. The scripts of fitwl.m, seconddecrease.m and second.m are used 
to determine the association rate constant of single-chain Cro variants perator DNA interactions 
from fluorescence data by nonlinear least squares (Figure 3.3). This set of scripts of fitu.m, 
increase.m and singleex.m are to fit the dissociation rate constant of single-chain Cro variant 
operator DNA interactions (Figure 3.4).  
The dissociation equilibrium measurements were carried out by direct titration and 
competition methods. The scripts of FF.m and CroDNAkdfit.m were used to fit the data in 
direct titration measurements (Figure 3.5). smkdfit.m and Ff.m are scripts to fit the competition 
data (Figure 3.6).   
               All scripts were written in MATLAB.  
 
5.1.5 fitwl.m, seconddecrease.m and second.m to obtain association rate 
constant 
fitwl.m 
function [x, resnorm] = fitwl(data) 
  
xdata = data(:,1); 
ydata = data(:,2); 
  
Fp = max(ydata)   %Fp; protein (donor)fluoroscence 
 
x(1) = 1e8 %Initial value of association rate constant          
                    
x(2) = 3e5 % Initial value of fluorescence from complex 
 
LB=[];UB=[]; 
Options=optimset(); 
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[x, resnorm] = lsqcurvefit('second', x,xdata,ydata,LB,UB,Options,Fp); 
%Solve nonlinear curve-fitting (data-fitting) problems in least-squares sense 
 
second.m 
function F = second(x, xdata, Fp)  
A0 = 1e-8  %initial donor concentration (protein concentration) 
K = x(1)   %association rate constant 
Fc = x(2)  %fluorescence from complex(obtained by adding access of DNA  
           %and assume that almost all the protein bound to DNA) 
  
A = A0./ (2* K * A0 .* xdata + 1) %free donor (free protein) 
F = (Fp/A0) .* A + (Fc/A0) .* (A0-A)% total fluorescence 
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seconddecrease.m 
 
%script to obtain association rate constant with calling second.m and fitwl.m 
file = '4.PRN'; 
% reads file 
data = dlmread(file, '\t', [0 0 100 1]);  
% reads data from the first upper left corner to the 100 lower right corner.  
[x, resnorm] = fitwl(data); 
 
Fp = max(data(:,2));  
%free total donor fluorescence  
F = second(x, data(:,1), Fp); 
 %call fuction second.m 
 
S1 = num2str(x(1), 3); 
S2 = num2str(x(2), 3); 
subplot(2,1,1), plot(data(:,1), data(:,2),'o', data(:,1), F,'r','linewidth',3) 
xlabel('Time (s)','FontSize',18); ylabel('Fluorescence(cps)', 'FontSize',18); 
maxt = max(data(:,1))   %max time 
maxf = max(data(:,2))   %max F 
minf = min(data(:,2))   %min F 
text((0.7*maxt), (minf + 0.95*(maxf-minf)), date) 
text((0.7*maxt), (minf + 0.7*(maxf-minf)), file) 
text((0.7*maxt), (minf + 0.8*(maxf-minf)), 'k =','FontSize',18) 
text((0.75*maxt), (minf + 0.8*(maxf-minf)), S1,'FontSize',18) 
text((0.7*maxt), (minf + 0.3*(maxf-minf)), 'Fc =') 
text((0.75*maxt),(minf + 0.3*(maxf-minf)), S2) 
text((0.7*maxt), (minf + 0.1*(maxf-minf)), 'Fi =') 
text((0.75*maxt), (minf + 0.1*(maxf-minf)), S3) 
resid= data(:,2)- F; 
 
subplot(2,1,2), plot(data(:,1), resid,'.') 
hline = refline([0 0]); 
set(hline,'color','r','linewidth',3) 
title ('residuals','FontSize',18) 
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5.1.6 fitu.m, increase.m and singleex.m to obtain dissociation rate constant 
fitu.m 
function [x, resnorm] = fitu(data) 
 
% x0 = [8e5 .001 1.2e6];  Amplitude, rate constant, F infinity 
xdata = data(:,1); 
ydata = data(:,2); 
x0(3) = max (ydata); 
x0(1) = min(ydata)-x0(3); 
x0(2) = 0.001  ;%change this manually to best guess for k 
[x, resnorm] = lsqcurvefit('singleex', x0, xdata, ydata); 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
138 
 
increase.m 
% tells matlab to look in this directory for functions and data 
%%increase.m 
%script to initialize data 
file = '3.prn'  
  
data = dlmread(file, '\t',[0 0 60 1]); 
%string is filename  
% reads data from the file FILENAME from the first value in the file. 
[x, resnorm] = fitu(data);  
F = singleex(x, data(:,1)); 
S1 = num2str(x(1), 3); 
S2 = num2str(x(2), 3); 
S3 = num2str(x(3), 3); 
S4 = num2str (resnorm, 3); 
subplot(2,1,1), plot(data(:,1), data(:,2),'O', data(:,1), F,'r','linewidth',2) 
 
xlabel('Time (s)','FontSize',16); ylabel('Fluorescence(cps)', 'FontSize',16); 
maxt = max(data(:,1))       %max time 
maxf = max(data(:,2))   %max F 
minf = min(data(:,2)) 
text((0.7*maxt), (minf + 1*(maxf-minf)), date) 
text((0.7*maxt), (minf + 0.7*(maxf-minf)), file) 
text((0.7*maxt), (minf + 0.5*(maxf-minf)), 'k =','FontSize',16) 
text((0.74*maxt), (minf + 0.5*(maxf-minf)), S2,'FontSize',16) 
%%text((0.7*maxt), (minf + 0.3*(maxf-minf)), 'A =') 
%%text((0.75*maxt),(minf + 0.3*(maxf-minf)), S1) 
%%text((0.7*maxt), (minf + 0.1*(maxf-minf)), 'Fi =') 
%%text((0.75*maxt), (minf + 0.1*(maxf-minf)), S3) 
%%text((0.4*maxt), minf , S4) 
%legend('smCro', 'Fit of smCro',4) 
xlabel('Time (s)','Fontsize',16);ylabel('Fluorescence (cps)','Fontsize',16); 
resid= data(:,2)- F; 
subplot(2,1,2), plot(data(:,1), resid,'.') 
hline = refline([0 0]); 
set(hline,'color','r','linewidth',2) 
title ('residuals','FontSize',16) 
%print –dps 
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Singleex.m 
 
function F = singleex(x, xdata)  
F = x(1) * exp(-x(2) * xdata) + x(3); 
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5.1.7 FF.m, CroDNAkdfit.m and mci.m to fit the data in direct titration 
measurements 
Crodnakdfit.m  
 
% x(1) =1.0e-11; 
x(1) =0.8e-9; 
  
Dt = 1e-9; % Dt = Donor concentrations 
xdata = [0 
0.1 
0.2 
0.4 
0.8 
1 
1.4 
1.8 
2.2 
2.6 
3 
3.6 
4.8 
7.2 
10.8 
14.4 
18.6 
30] * 1e-9; 
  
ydata = [357552 
357440 
346166 
329223 
307786 
300389 
277581 
259633 
253491 
246224 
234393 
224434 
210064 
202081 
192180 
189857 
185013 
180121]; 
  
  
x(2) = max(ydata); 
x(3) = min(ydata); 
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LB=[];UB=[] 
 
Options=  optimset;%('Tolx',1e12,'MaxFunEvals',1e8,'MaxIter',1e8); 
[X,RESNORM,RESIDUAL,EXITFLAG,OUTPUT,LAMBDA,JACOBIAN] = 
lsqcurvefit('FF',x,xdata,ydata,LB,UB,Options) 
  
xdata1 = 0:5e-10:3e-8; 
B = X(1) + Dt + xdata1; 
Y1 = X(2) - ((X(2) - X(3))./Dt*(B - sqrt(B.^2 - 4.*xdata1.*Dt))./2); 
plot(xdata,ydata,'o',xdata1,Y1,'linewidth',3); 
set(gca,'FontSize',16); 
CI = mci(X, RESNORM, JACOBIAN, 0.95); 
title('Nhis-c3-SM-Cro DNA Binding'); 
xlabel('[DNA] (M)','Fontsize',16); 
ylabel('Fluorescence (cps)','Fontsize',16); 
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FF.m 
function CF = FF(x, xdata) 
  
Dt = 1e-9; 
K = x(1); 
Fmax = x(2); 
Fmin = x(3); 
  
At = xdata; 
B = K + Dt + At; 
CF = Fmax - ((Fmax - Fmin)./Dt*(B - sqrt(B.^2 - 4.*At.*Dt))./2); 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
143 
 
mci.m 
 
function ci = mci(b,resnorm,J,level) 
% Converted from CONFINT  Confidence intervals for the coefficients of a fit 
result object. 
%   calls mtinv, mbetainv, mbetacdf, mbetapdf 
% 
%   CI = MCI(b,resnorm,J,level) specifies the confidence level. 
%   LEVEL must be between 0 and 1, and has a default value of 0.95. 
  
%  b        is the parameters of the fit (xf from lsqcurvefit) 
%  resnorm  is the sum of the squares of the residuals (sse) 
%  J        is the jacobian matrix of size [m n] 
%               where m is the number of data points (rows) and 
%                     n is the number of parameters (columns) 
  
% Covariance matrix of fitted parameters is 
%    V = inv(X'*X) * (sse/dfe) 
% and the confidence intervals are 
%    b +/- sqrt(diag(V)) * tinv(1-(1-level)/2, dfe) 
  
  
if nargin<4, level = 0.95; end 
if length(level)~=1 | ~isnumeric(level) | level<=0 | level>=1 
   error('Confidence level must be between 0 and 1.'); 
end 
  
[m,n] = size(J); 
sse = resnorm;      %sum of the squared errors, also called the 2 norm of the 
residual 
dfe = m-n;          %degrees of freedom 
  
%calculate covariance 
[Q R] = qr(J,0); 
Rinv = R\eye(size(R)); 
  
if dfe<=0 
   error('Cannot compute confidence intervals if 
#observations<=#coefficients.'); 
end 
  
% X=Q*R, so X'*X = R'*Q'*Q*R = R'*R. 
% The inverse is Rinv*Rinv' and the diagonals of that can be 
% computed using the sum expression on the following line. 
v = sum(Rinv.^2,2) * (sse / dfe); 
%b = cat(1,fun.coeffValues{:})'; 
% b= x; 
alpha = (1-level)/2; 
%t = -mtinv(alpha,dfe); 
t = tinv(alpha,dfe); 
%db = NaN*zeros(1,length(activebounds)); 
  
144 
 
db = t * sqrt(v'); 
ci = [b-db; b+db]; 
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5.1.8 smkdfit.m, Ff.m and mci.m to obtain equilibrium constant by competition 
method 
smkdfit.m 
 
x(1)=6.5e-10 
Kor=1.0e-11 
Ot =1.0e-9; % Ot = OPERATOR OR3  concentrations 
Rt =1.0e-9; % Rt = REPRESSOR SM concentrations 
xdata = [0 
    5 
    10 
    20 
    40 
    60 
    80 
    100 
    120 
    140 
    160 
    180 
    200 
    220 
    240 
    260 
    280 
    300] * 1e-9; 
  
ydata = [203795 
    216262 
    222321 
    230483 
    242781 
    252243 
    259400 
    263477 
    266805 
    271069 
    273298 
    273717 
    275615 
    276933 
    277315 
    279459 
    280079 
    278687]; 
  
LB=[];UB=[]; 
% LB=[1.0e-13 120000 40000];UB=[1.0e-01 130000 63000]; 
Options=  optimset;%('Tolx',1e12,'MaxFunEvals',1e8,'MaxIter',1e8); 
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[X,RESNORM,RESIDUAL,EXITFLAG,OUTPUT,LAMBDA,JACOBIAN] = 
lsqcurvefit('Ff',x,xdata,ydata,LB,UB,Options) 
  
xdata1 = 0:5e-11:3e-7; 
B = Ot+Rt+Kor*(1+(xdata1/x(1))); 
% Y1 = X(2) - ((X(2) - X(3))./Dt*(B - sqrt(B.^2 - 4.*xdata1.*Dt))./2); 
Y1 = 3.0e5-(6.0e4*(B - sqrt(B.^2 - 4.*Ot.*Rt))/Ot) 
plot(xdata,ydata,'o',xdata1,Y1,'linewidth',3); 
set(gca,'FontSize',16); 
CI = mci(X, RESNORM, JACOBIAN, 0.95); 
%title('SM-Cro DNA Binding by competition experiment'); 
xlabel('[SM-Cro (Mt)] (M)','Fontsize',16); 
ylabel('Fluorescence (cps)','Fontsize',16);  
%legend('Data','Fit'); 
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Ff.m 
function CF = Ff(x, xdata) 
  
Kor=1.0e-11 
Ot =1.0e-9;  
Rt =1.0e-9 
K = x(1); 
Dt = xdata; 
B = Ot+Rt+Kor*(1+(Dt/K)); 
thelta =(B - sqrt (B.^2 - 4.*Ot.*Rt))/(2*Ot); 
  
CF = 3.0e5 + (1.8e5 - 3.0e5)* 1e-9* thelta 
  
%CF = 3.0e5 -(6.0e4*(B - sqrt(B.^2 - 4.*Ot.*Rt))/Ot); 
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